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EXECUTIVE SUMMARY 
Pain is a common symptom of cancer and it significantly affects the diagnosis, quality 
of life and survival of patients with cancer.  Opioids are the mainstay in managing 
cancer-related pain.  However, cancer patients’ adherence to opioid analgesics were 
reported to be less-than-desirable (63.6% for around-the-clock opioid analgesics and 
30.9% for as-needed opioid analgesics in a study among Taiwanese oncology 
patients)[1].  Without proper adherence to prescribed opioid regimen, severe cancer 
pain cannot be adequately controlled[2]. 
 
Beliefs about opioids are rooted in their use and misuse in history, resulting in social 
stigma attached even to their legitimate use in cancer-related pain. As a consequence, 
they evolved to become significant barriers to cancer pain management by 
contributing to opioid medication non-adherence[3]. 
 
Self-management with prescribed opioid regimen has become an integral part of 
cancer pain experience at home[4]. Thus, the specific skills and behaviors needed by 
patients to effectively manage their opioid pain relievers has also become critically 
important in determining the degree to which opioids are adhered to. As a result, an 
understanding of this potentially modifiable variable may allow us to predict and 
hopefully serve as points of interventions to improve opioid medication adherence. 
 
Patients’ beliefs regarding opioid usage and their self-efficacy are largely unstudied in 
Singapore.  Their relationships to opioid medication adherence have been evaluated 
only in limited studies in other countries such as the United States and Taiwan[5-7].  




The work in this thesis will allow us to strengthen the understanding of how these 
patient attributes affect opioid adherence in the local context, specifically in cancer 
patients. 
 
This thesis began with a systematic literature review that identified the contexts 
in which studies related to cancer  patients’ beliefs have been performed. In the 
systematic literature review, we also described and appraised the  content and 
psychometric properties of the measurement tools for assessing cancer patient 
beliefs. This led us to single out the POABS-CA as a potentially valuable 
instrument to use in our population to understand how these patient attributes 
can affect opioid adherence. While several instruments, such as Beliefs in 
Medicines Questionnaire (BMQ) and the Barriers Questionnaire (BQ), have been 
developed to study patients’ beliefs affecting medication adherence, only the 
Pain Opioid Analgesics Beliefs Scale-Cancer (POABS-CA) is specific to both 
cancer patients and to opioid medications. The POABS-CA, based on Agency for 
Health Care Policy and Research (AHCPR) cancer pain guidelines and culturally 
related pain beliefs observed in clinical settings, was designed by a Taiwanese 
research team to measure negative effect beliefs about opioids (belief that 
opioids will have negative effects on the body) and pain endurance beliefs (belief 
that one should endure as much pain as possible). Validation of the POABS-CA in 
our local setting will enable us to ascertain if the domains identified by the 
Taiwanese research group is similarly regarded as important and relevant by 
our patients. Hence, part of the thesis reported on the evaluation of the validity 
and reliability of the POABS-CA, which was found to show satisfactory feasibility 




and reliability. However, unlike the Taiwanese study, the same construct validity 
was not observed. 
 
We acquired the trend of opioid usage in a local ambulatory cancer center to 
obtain baseline understanding of our opioid consumption. We have found that, 
despite increases in cancers diagnosed, our usage of opioids remained relatively 
stable.  However, a rise in the use of stronger opioids such as oxycodone is 
observed. As serious problems associated with increased usage of stronger 
opioids overseas have been reported, we should watch our population closely as 
we continue to prescribe suitable analgesics for our patients .  
  
In conclusion , this thesis has laid the groundwork by providing an 
understanding of opioid usage trends and issues in Singapore among cancer 
patients, particularly in the area of cancer pain beliefs and the consequent 
adherence to opioid painkillers. The impact of cancer patients’ beliefs has been 
studied in a variety of contexts but there is a general lack of well-designed 
studies. Several other contexts where cancer patient beliefs may play a role has 
not been explored and could be areas for future research . Much needs to be 
done to gain a better understanding of these issues and to develop strategies to 
address them. Although the POABS-CA may not be readily useable in our patient 
population, our results are nevertheless useful in informing the design of future 
studies to understand cancer pain beliefs in relation to patients’ adherence to 
opioid painkiller medications. 
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Specific Aims   




 Long-term objective 
i. To enhance understanding of how patients’ beliefs affect adherence to 
supportive care. Supportive care here refers to medical and surgical issues 
concerning supportive therapy and care, which may supplement basic 
treatment of the disease[8]. 
 
Goals of research 
i. To broadly outline the contexts in which studies related to cancer patients’ 
beliefs have been performed via a systematic review. 
ii. To identify a valid and reliable questionnaire for assessing cancer patients’ 
opioid medication beliefs in the local context  
iii. To ascertain the trends in opioid use in a large local ambulatory cancer 
center to enable us to obtain a baseline understanding of opioid usage in 
our local setting 
iv. To ascertain the reliability and validity of existing instrument identified in 
(ii) for opioid beliefs among Singaporean patients with cancer. 
v. To determine the association between cancer patients’ medication beliefs 
and cancer therapy adherence among local patients using the questionnaire 
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Patients’ beliefs as an important component in the total concept of care in 
oncology  
Cancer is a complex and varied disease.  For cancer care to be dependable and 
efficient, it has to be considered as a structure, functioning as an interconnected 
organization of operations with the same goal[9].  As a result, multidisciplinary 
cancer care is now viewed as necessary in delivering the total concept of care in 
oncology[10].  Total concept of care in oncology refers to holistic view of medical 
care that is relevant to a cancer patient, including anti-cancer treatment, supportive 
care, attention to mental health, emotional health, as well as spiritual needs.  This 
patient management system increasingly involve representation of healthcare 
professionals from various disciplines as patient management continue to expand to 
envelop areas such as treatment, management of side effects, psychosocial support 
and end-of-life issues. Previous studies have reported that cancer patients’ beliefs 
regarding pain and pain medications affected the way they viewed cancer-related pain 
and opioids[7], spiritual aspects of coping with cancer[11] and even the way they 
viewed their own illness[12].  Hence, we hypothesized that patients’ beliefs are 
critical in the total concept of care in oncology, where every part of medical care in a 
cancer patient is relevant. We then embarked on a systematic literature review (study 
#1) to identify research gaps in this subject area. Specifically, we sought to (i) identify 
any component of the total concept of care in oncology where patients’ beliefs have 
not been well studied and (ii) either cross culturally adapt or develop new measures of 
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Patients’ beliefs in Supportive Care 
As stated earlier, we are also interested to evaluate how patient’s beliefs may impact 
on the receipt of supportive care in cancer, specifically in the area of pain 
management.  
Pain is a common symptom of the disease process in a patient’s journey in cancer.  
World Health Organization (WHO) recommends that analgesics should be given “by 
the clock” rather than “on demand” in order to maintain a pain-free condition in 
cancer patients [13]. In support of this recommendation, WHO has developed a three-
step cancer pain ladder for adult patients, where prompt oral administration of drugs 
is advised in the following manner: first non-opioids, followed by mild opioids such 
as codeine phosphate, and finally strong opioids such as morphine sulphate, until a 
pain-free state has been achieved in each cancer patient. Despite the World Health 
Organisation’s (WHO) recommendations, inadequate management of cancer pain 
remains a major problem.  The prevalence of chronic pain is about 30–50% among 
patients with cancer who are undergoing active treatment for a solid tumour[14-16] 
and 70–90% among those with advanced disease[17-21]. The prevailing health care 
provider-related impediments include inadequate pain assessment, dearth of expertise 
and doctor’s hesitancy at prescribing opioids[22, 23].  System-related obstacles 
restrict patients’ or physicians’ access to opioid analgesics or even limit availability of 
pain experts.  However, most pertinent to our study are patient-related barriers, which 
include mental and emotional factors as well as adherence to pain management 
plans[24]. 
Opioids are established as the cornerstone of cancer pain treatment by the WHO since 
1990[25] and morphine is recommended by the European Association for Palliative 
Care as the benchmark “step 3” opioid according to the WHO ladder[26]. 




Despite opioid analgesics being the mainstay for management of cancer-related pain, 
there have been reported barriers to the use of opioids for pain relief[23, 27-29], 
particularly concerns with potential addiction, the perceived need to tolerate cancer 
pain without use of opioids and that opioids should only be reserved for use later in 
the course of cancer due to the belief that use of opioids earlier would render them 
less effective in the advanced stages of the disease.  There were also reports of  
patients’ beliefs that the introduction of morphine was a metaphor for impending 
death, as patients and their caregivers commonly viewed the use of morphine as a last 
resort in their treatment[29].  
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Systematic review of measures of cancer patients’ beliefs 
Identified knowledge gaps 
We performed a  systematic literature review (Chapter 1) of studies published in 
MEDLINE and Cochrane Trials before July 2015. From this systematic literature 
review of cancer patients’ beliefs we confirmed that the relationship between cancer 
patients’ beliefs and their adherence to both cancer therapy and supportive care are 
current knowledge gaps in the study of cancer patients’ beliefs. This led us to propose 
several related studies to further contribute to this subject area.  
 
Prevalence data on opioid consumption patterns in NCCS 
Reported local data 
We reported local data on trends in current opioid usage. This information is 
important in several ways. The International Narcotics Control Board (INCB) 
provides national-level opioid usage data which includes both cancer and non-cancer 
usage patterns.  Our study is pertinent to our interest to acquire opioid usage patterns 
specific to cancer use.  This information can be important to allow decision makers to 
anticipate associated harms with increased consumption of opioids and to potentially 
mitigate by increasing emphasis on adherence to opioids. 
 
Evaluation of validity and reliability of POABS-CA 
A valid and reliable tool for assessing cancer patients’ beliefs on opioid analgesics is 
required as we seek to evaluate the association between patients’ beliefs and opioid 
usage.  
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Measure of cancer patients’ opioid beliefs and their adherence to opioid 
analgesics 
Lack of local data 
The NCCS has a busy specialist outpatient clinic (SOC) with more than 100,000 
patient attendances annually. To date the Centre has limited resources and services 
that specifically cater to medication management needs of cancer patients. With 
regards to opioid analgesic use, we assumed that patients and their caregivers are able 
to manage their own medication safely. We do not have a system that actively seeks 
patients who potentially have problems with their treatment or handling of drugs. 
Little is also known about the medication adherence of patients who receive opioid 
analgesics for cancer pain.  
 
The findings from this study will be used as baseline information for future resource 
and service allocations to cater to the needs of patients on opioid analgesics. By 
understanding the association between patients’ beliefs on opioid analgesics and how 
this influences their adherence to opioids, we will be able to identify patients at risk 
for opioid analgesic non-adherence as well as improve the rate at which these patients 
adhere to their cancer pain regimen. 
 
By enhancing our understanding of patients’ opioid beliefs and their adherence to 
opioid analgesics, we will be able to identify patients at risk for opioid non-adherence. 
This will allow the future design of tailored interventions targeted at these patients 
and would be a more cost-effective approach than a one-size-fits-all intervention.  
  











Chapter 1. Systematic review of measures of cancer patients’ beliefs 
  





Cancer is a leading cause of death in many societies globally, with approximately 14 
million new cases and 8.2 million cancer related deaths in 2012[30]. The annual 
cancer cases is expected to continue to increase from 14 million in 2012 to 22 million 
within the next two decades[30].  
Approach to dealing with cancer by health care professionals have conventionally 
involved first a clinical diagnosis of the patient’s condition followed by structured 
plans for treatment and ancillary care by consulting with evidence-based, consensus-
driven management guidelines that serve to ensure that their patients receive 
treatment and supportive services that are most likely to lead to optimal outcomes.  
However, patients themselves deal with the disease very differently and their 
preferences and decisions should not be overlooked.  
Patients’ perspectives can play critical roles in the management of their own illness 
[31]. A patient’s cancer beliefs can potentially influence how an individual perceives 
treatment modalities, likely courses of the disease journey, as well as the significance 
of the disease on their lives. For example, in a study[32] among 425 patients with 
diverse malignancies treated at a large academic oncology center, perceived disease 
severity was a significant predictor of participation in patient support groups after 
adjusting for disease site and other potential confounders [32]. Likewise, these 
inherent qualities[33] that patients harbor were also shown to effect the outcome of 
patients’ mindset and behavior in their disease management. For example, in a 
study[33] among 1075 childhood cancer survivors, the perception that regular follow-
up is not necessary was the only significant predictor of follow-up attendance after 
adjusting for other health beliefs, medical and demographic variables[33]. Hence, 
patients’ beliefs are important in the potential success of cancer management. 




However, most of the literature has focused on the understanding of how health 
beliefs of the general population influence cancer-screening uptake[34-36] in various 
parts of the world, such as among Hispanics, immigrant and ethnic minorities in the 
US and globally. A review identified a body of knowledge in the area of Indigenous 
beliefs about biomedical and bush medicine treatment efficacy for Australian 
indigenous cancer patients[37]. To the best of our knowledge, there is no other 
systematic review that summarizes current literature with regards to the areas of focus 
in which cancer patients’ beliefs have been studied. The areas of focus are the 
common primary objectives of the individual studies in this review, of which we have 
segregated into five distinct groups. We are particularly interested to evaluate if the 
current measurement tools for assessing cancer patient beliefs are sufficiently 
comprehensive and robust for their intended purposes within each context. Hence, the 
purpose of this systematic literature review is to broadly outline the contexts by 
summarizing the studies within each area of focus in which studies related to cancer 
patients’ beliefs have been performed. In addition, we would critically appraise the 
content and psychometric properties of the measurement tools for assessing cancer 




A literature search of studies published in MEDLINE and Cochrane Trials before July 
2015 was undertaken. The search terms and study inclusion criteria were intentionally 
broad. We included studies of participants diagnosed with cancer, who were asked for 
their own beliefs regarding any aspect of cancer. The inclusion criteria are studies of 
participants diagnosed with cancer, who were asked for their own beliefs regarding 




any aspect of cancer. The exclusion criteria are studies unrelated to cancer or related 
to cancer screening, as well as studies that did not measure patients’ beliefs, or that 
the measurement of beliefs were those of the general public or health care 
professionals instead of patients. Non-English articles are also excluded. Articles 
published only as abstracts were excluded.  The time frame was 10 years from 2006 
to 2015. 
 
The keywords “belief”, “questionnaire” and “cancer” were used, with the following 
search details: (("culture"[MeSH Terms] OR "culture"[All Fields] OR "belief"[All 
Fields]) AND ("questionnaires"[MeSH Terms] OR "questionnaires"[All Fields] OR 
"questionnaire"[All Fields]) AND ("neoplasms"[MeSH Terms] OR "neoplasms"[All 
Fields] OR "cancer"[All Fields])) NOT "quality of life"[All Fields] AND ((Clinical 
Trial[ptyp] OR Journal Article[ptyp] OR Review[ptyp] OR systematic[sb] OR Meta-
Analysis[ptyp] OR Randomized Controlled Trial[ptyp]) AND "2005/08/06"[PDat] : 
"2015/08/03"[PDat] AND "humans"[MeSH Terms] AND English[lang] AND 
cancer[sb]). While randomized controlled trials (RCTs) and controlled trials are the 
most robust, it is not anticipated that many studies of these designs will be available 
in this field.  Therefore, if information from controlled trials is not available, other 
studies such as cohort and cross-sectional studies as well as meta-analyses and 
systematic reviews are eligible for inclusion. Besides conducting database analysis, 
we hand-searched the bibliography of included articles for additional articles.  
 
Two investigators independently reviewed the abstracts and full-text articles against 
the pre-specified eligibility criteria.  One investigator extracted details about the study 
design, patient sample, setting, and results. Another investigator verified the extracted 




data for accuracy. Two investigators independently assessed the quality of each study 
by applying Newcastle-Ottawa quality assessment scale in terms of the number of 
stars accrued, where appropriate.  Discrepancies were resolved through a consensus 
process. We then organized the included articles according to the contexts of inquiry 
(subsequently referred to as areas of focus), according to the articles’ primary 
objectives as our guiding principle. This process involved both investigators 
separately categorizing the articles with similar focus as identified by their primary 
objectives under their relevant categories. Discrepancies were resolved through a 
consensus process. Within each context, we summarize the work that has been done 
and provide a list of measurement tools for cancer patient beliefs that is available. We 









The literature search, exclusion and selection are summarized in Figure 1.  Database 
searches resulted in 657 potentially relevant articles, whose titles and abstracts were 
dual-reviewed, leaving 29 articles that met our inclusion and exclusion criteria. 423 
articles were rejected due to their titles being unrelated to cancer or were related to 
cancer screening. 172 articles were further rejected due to their abstracts showing that 
the studies did not measure patients’ beliefs, or that the measurement of beliefs were 
those of the general public or health care professionals instead of patients’. Finally, 30 
articles rejected after the investigators read the full text and found that the studies did 
not measure patients’ beliefs, or that the measurement of beliefs were those of the 
general public or health care professionals instead of patients. We identified no 
studies conducted as randomized controlled trials and other than two large, good-
quality cohort studies, the rest of the studies were cross-sectional in nature. The 
resultant articles were then grouped according to the focus of their studies and will be 
subsequently discussed. Table 1.2 shows a summary of the studies reviewed while 
Table 1.3 compiles the questionnaires measuring cancer patients’ beliefs found in the 
studies. 
  





Figure 1: Literature search, exclusion and selection 
Areas of focus 
The shortlisted studies may be organized into five areas of focus, namely: views on 
treatment acceptance, health status, adherence, coping with cancer and 






3 duplicates removed 
423 articles rejected due to 
Title being unrelated to 
cancer or are related to 
cancer screening 
172 articles rejected due to 
Abstract showing that 
studies did not measure 
patients’ beliefs, or that the 
measurement of beliefs 
were those of the general 
public or health care 
professionals instead of 
patients 
30 articles rejected after 
reading full text showing 
that studies did not measure 
patients’ beliefs, or that the 
measurement of beliefs 
were those of the general 
public or health care 
professionals instead of 
patients 




Table 1.1 - Studies on cancer patients’ beliefs 
Focus Number of studies 
Cancer Beliefs and Treatment 
Acceptance 
3 
Cancer Beliefs and Health Status or 
Health Behavior 
9 
Cancer Beliefs and Treatment 
Adherence 
7 
Cancer Beliefs and Coping with 
Cancer 
7 





Cancer Beliefs and Treatment Acceptance 
A total of three studies evaluated the association between cancer patient beliefs and 
treatment acceptance. Negative beliefs about cancer treatments have been associated 
with patients’ low acceptance of recommended cancer management plans.  A study in 
Australia by Cohen et al (n = 126) found that a significant proportion of the patients 
surveyed (41%) possessed strong negative beliefs about the addictive potential of 
opioid analgesics [5]. The authors postulated that the strong negative beliefs might 
explain why only 40.4% of patients decided to receive a portion of painkillers 
available to them despite experiencing moderate to severe pain in the 24 hours prior 
to being interviewed. In a cross-sectional study by Liang et al in Taiwan (n = 92), 
33.7% believed that “opioid medicine should only be used at the last stage of an 
illness” and 68.5% believed that “opioid medication is not good for a person’s body”. 
This showed that a similarly large proportion of respondents had misconceptions 
about opioid analgesics and the concept of pain management[7]. However, the 




Taiwanese study did not evaluate if the misconceptions were associated with 
treatment acceptance.  
Akiyama et al conducted a nation-wide survey in Japan to study advanced cancer 
patients’ perception, knowledge as well as concerns about use of opioid painkillers, 
palliative care and homecare[27].  While 1,619 questionnaires were sent, 925 
responses have been received. In particular, 30% of patients were shown to believe 
that use of opioid painkillers can result in addiction or reduce one’s lifespan.  About 
half also erroneously believed palliative care to be reserved only for those in the final 
stages of the disease. 
Cohen et al utilized the American Pain Society’s (APS) Patient Outcome 
Questionnaire, which has been established as a valid and reliable instrument to 
measure pain[38-40] and has been translated into various languages[39, 40].  It is a 
patient-reported outcome (PRO) on pain intensity, the degree to which pain affects 
their mood and daily living activities, pain beliefs and attitudes and their 
management, and their satisfaction with inpatient pain management. 
Liang et al used the Pain Opioid Analgesic Beliefs Scale – Cancer (POABS-CA) to 
measure cancer patients’ beliefs in pain and opioid analgesics using 10 items on a 5-
point Likert-type scale. Cronbach’s alpha was calculated to be 0.70 and test-retest 
reliability was 0.94. Factor structure was confirmed and known group, as well as face, 
validities were supported. It was also shown to possess satisfactory reliability and 
validity, and consists of two factors, pain endurance beliefs and negative effect 
beliefs.  Using this instrument, Liang et al found association between patients’ 
negative beliefs in opioids and their treatment adherence to opioid analgesics.  It was 
however validated only among Taiwanese cancer patients.   




Akiyama et al’s survey consisted of two items to assess opioid knowledge and belief: 
“opioids can relieve most pain caused by cancer” and “opioids are addictive and/or 
shorten life”.  Three items were utilized to measure patients’ beliefs about palliative 
care: “palliative care relieves pain and distress”, “palliative care is provided along 
chemotherapy and/or radiation therapy” and “palliative care is only for terminally ill 
patients”.  Each of these five items was answered along a 5-point Likert scale (1: 
strongly disagree, 2: disagree, 3: unsure, 4: agree, 5: strongly agree). 
 
Cancer Beliefs and Health Status or Health Behavior 
A total of nine studies evaluated the relationship between cancer patient beliefs and 
health status. Among these, six studies evaluated beliefs about the etiology of cancer 
and health status. For example, one large, fair-quality cohort study (n = 1489) by 
Panjari et al found that stress (58.1%) was the most common cause attributed to the 
development of cancer[41]. Women who believed in this had lower Psychological 
General Well-being Index (PGWB) scores than others (70.9±16.1, n=361 versus 
77.3±14.9, n=1071, mean difference=6.4, 95% CI: 4.6–8.2 p<0.0001). Interestingly, 
they were also more inclined to adopt strategies to reduce stress. In another study, 
Costanzo et al showed that women with cervical or endometrial cancer reported stress 
as the second most important cause of cancer, preceded by genetics[42]. It was found 
that stronger causal attributions tended to be associated with symptoms of depression 
and anxiety. As with the previous study, women with stronger causal attributions also 
tend to be more inclined to practise healthy behaviors.  In a third study, Thuné-Boyle 
et al demonstrated that belief of the consequence of their illness was found to be a 
critical determinant of distress in patients, explaining 15% of the variance in anxiety 
and 5% of that in depression[43].  A small study (n = 28) by Obeidat showed that fear 




played a dominant role in Jordanian women’s breast cancer journey, where it shaped 
their experience with their illness and its associated treatment[44]. Another study in 
UK by Lord K et al found that a minority of British South Asian (BSA) patients held 
strong beliefs in supernatural causes of cancer[45].  
Besides belief about etiology of cancer, two other studies evaluated the belief on 
cancer severity and health behavior. For example, Ermiah et al discovered that the 
seemingly lackadaisical belief on the gravity of cancer has contributed to the view 
that breast cancer symptoms are not serious and this has been shown to result in 
delays in clinical diagnosis of breast cancers in Libya, where the median diagnosis 
time was 7.5 months and only 30% of patients were diagnosed within 3 months upon 
presentation of symptoms[46]. Another study in the USA by Costanzo et al found that 
among women treated with adjuvant chemotherapy and/or radiotherapy, those who 
viewed their cancer to have graver consequences were also the most likely to develop 
positive changes in their lifestyles[47].  
Kumar et al showed that cancer patients in Pakistan possessed unique beliefs and 
concerns about the disease that physicians should be aware of[48].  A significant 
proportion of patients in the study (27%) were of the opinion that cancer was 
contagious and majority (75.2%) sought alternative treatments (faith healing, 
homeopathy) prior to an appointment with their oncologists. 
A study in Canada by Nadler et al on osteoporosis knowledge and beliefs among men 
with prostate cancer on androgen-deprivation therapy (ADT) revealed that patients 
lack knowledge on osteoporosis as well as self-efficacy[49].  These patients also 
neither view themselves as susceptible to osteoporosis nor approached the issue 
(osteoporosis) with the appropriate gravity due to the condition.  As a result, many 
failed to practice healthy bone behaviors.  




Ermiah et al used a semi-structured interview conducted by a physician to collect data 
including patients’ sociodemographics and medical history.   
Kumar et al designed a set of questionnaire themselves from review of studies done in 
South Asia.  It covered themes of current cultural practices and religious beliefs, and 
also included patient-level information on education levels, employment statuses, as 
well as knowledge and beliefs regarding cancer risk and treatments. 
Lord K et al utilized six questionnaires in his study: which include the Mini- Mental 
Adjustment to Cancer (Mini-MAC) and the Physician/Patient Trust and Cancer 
Beliefs questionnaire, a questionnaire on patient’s opinions on confidentiality 
outcome and cancer management. The Mini-MAC is a revised version of the Mental 
Adjustment to Cancer (MAC) and its purpose is to measure the coping styles that 
cancer patients have when diagnosed with the disease. 
The set of questionnaires employed by Nadler et al included the Osteoporosis Health 
Belief Scale (OHBS) to measure health beliefs  in the domains of perceived 
osteoporosis susceptibility, seriousness about osteoporosis and general motivation to 
health. 
Panjari et al administered three separate questionnaires to her subjects: enrollment 
questionnaire (EQ) about 41 weeks upon diagnosis of breast cancer, follow-up 
questionnaires 1 (FQ1) 12 months from EQ, and FQ2 which was administered 24 
months from completing EQ.  The EQ consisted of background information such as 
demographics and details of the disease as well its treatment.  FQs record ongoing 
medical management of the disease as well as changes in lifestyles.  FQ2 additionally 
included the Psychological General Well-Being Index (PGWB), a 22-item 
questionnaire to assess psychological well-being. 




Thuné-Boyle et al used the Illness Perception Questionnaire (IPQ) in his study.  More 
accurately, the study used two subscales from IPQ that was adapted for breast cancer 
patients, to measure breast cancer patients’ beliefs about the potential for cure of the 
disease, as well as the ramifications of cancer and its management. 
Costanzo et al, in the study on breast cancer patients, attempted to measure two 
aspects: health practices and common-sense models of cancer.  To perform the 
former, the research group asked the patients, via the questionnaire, on health 
behavior changes after the cancer diagnosis as well as the degree to which the patients 
participated in the health practices.  The Illness Perception Questionnaire-Revised 
(IPQ-R) was utilized to measure the patients’ beliefs about their disease. 
In a separate study on gynecologic cancer survivors, Costanzo et al used a set of 
questionnaires.  The were two that measured cancer patients’ beliefs: cancer 
attributions was measured by asking patients to rate the importance of several factors 
in how they contribute to cancer development as well as prevent recurrence; cancer-
related worry was assessed by using the Concerns About Recurrence Scale (CARS), 
of which only measures general fear of recurrence of cancer (4 items) was used in this 
study. 
  
Cancer Beliefs and Treatment Adherence 
Seven studies evaluated the association between cancer beliefs and treatment 
adherence. One large, good-quality cohort study (n = 1075) by Michel et al on 
adherence to follow-up care for survivors of childhood cancers in Switzerland found 
that belief about the importance of follow-up was the single most important predictor 
to self-reported attendance at follow-up after adjusting for other health beliefs, 
sociodemographic and clinical variables[33].A Taiwanese study by Liang et al 




showed that patients’ beliefs about pain and opioid analgesics were significantly 
associated with adherence to these opioids (r = -0.30, p < 0.01)[24].  Patients were 
also noted to have worse adherence to around-the-clock (ATC) pain management 
regimens when they reported more misconceptions about pain and opioids.  This is 
cogent as opioids, despite being the mainstay of cancer pain management, bring with 
them significant negative social stigma such as fear of addiction, side effects, as well 
as its reputation as a herald of impending death[29].   
This was contradicted in a Norwegian study by Valeberg et al where their patients’ 
barrier scores as measured using the Barriers Questionnaire–II (BQ-II) were not 
associated with their adherence scores[50].  The authors postulated that this could be 
due to patients not always reacting to their own concerns about how they felt about 
opioids by not being adherent to their pain regimen. 
In terms of oral chemotherapy, one Greek study by Sarasiotou et al found that 
unintentional non-adherence to oral chemotherapy was most prevalent among those 
patients who believed that their treatment was ineffective (62.5%, p=0.03)[51].  As a 
result, it was concluded that patients’ beliefs about treatment efficacy seemed to be a 
significant determinant of adherence to oral chemotherapy.   
As part of oral anticancer treatment, adjuvant endocrine therapy has also seen 
problems related to patients’ beliefs.  Tamoxifen non-adherers were more inclined to 
also hold the belief that taking the medication would not benefit them[52], as 
illustrated in a UK study of breast cancer patients performed by Grunfeld et al.  
Sherman et al found that adherence to lymphedema risk minimization strategies by 
cancer patients who have undergone breast surgery was associated with belief in 
gravity of consequences of not adopting this practice[53]. 




Salz et al in a study in USA[54] found that while colorectal cancer survivors remain at 
risk of recurrence, not all continue with follow up colonoscopies.  The research team 
found that a greater perceived susceptibility to colorectal cancer among these patients 
was associated with greater motivation to have a colonoscopy (OR=2.00, 95% 
CI=1.16–3.44).  In addition, those who already had a colonoscopy since their 
diagnoses were associated with greater motivation to have a colonoscopy in the future 
(OR=9.47, 95% CI=2.08–43.16). 
Sherman et al adapted a questionnaire that was originally created for genetic testing 
research for his study on lymphedema risk minimization.  It consisted of four 
subscales that measured different cognitive facets that affect adherence to 
lymphedema risk minimization recommendations.   
Michel et al used a questionnaire to answer mainly two questions: follow-up care and 
health beliefs.  The health belief portion included measures of perceived susceptibility 
to late effects of past cancer treatments on a 10cm visual analogue scale, while 
severity of late effects was measured on 4-point Likert-type scale.  In addition, 
benefits and barriers to follow-up care were assessed, as well as importance of health 
to the individual and beliefs on detecting and treating late effects of cancer treatments 
early. 
Sarasiotou et al utilized a 7-page questionnaire that asked the following aspects of 
cancer care: demographics, belief in objective of oral chemotherapy, self-report 
adherence to treatment, intentional/unintentional missing of dose, reasons for missing 
dose, ways to improve adherence and side effects experienced from treatment, among 
other questions. 
The study by Valeberg et al employed the use of the Brief Pain Inventory (BPI), two 
self-report instruments to measure adherence with pain management regimen, a 22-




item self-efficacy questionnaire and the Barriers Questionnaire-II (BQ-II).  The BPI 
measures pain intensity, pain relief from medications as well as the extent to which 
pain has interfered with daily life.  The 2 questionnaires on medication adherence 
were the 4-item Morisky’s Medication Adherence Scale (MMAS-4) and a single-item 
adherence question with five response options developed by Lai Y H et al[55]. The 
self-efficacy questionnaire was originally developed for arthritic patients and included 
three subscales: self-efficacy for pain management, self-efficacy for physical function 
and self-efficacy for coping with pain as well as other symptoms. 
Grunfeld et al used a set of four questionnaires, of which the Beliefs in Medicines 
Questionnaire (BMQ)[56] contains two sections: the BMQ-Specific and the BMQ-
General.  These two sections can be used separately or in combination.  It was 
developed based on beliefs found to be common among patients suffering from 
chronic illnesses such as asthma, diabetes and psychiatric conditions.  The internal 
consistency and test-retest reliability were found to be good, and the criterion and 
discriminant validity were satisfactory.   
The Barriers Questionnaire (BQ)[57] was developed in 1993 in USA to assess cancer 
patients’ reluctance to report pain and use analgesics.  This was updated to the 
Barriers Questionnaire–II (BQ-II)[58] which was used in this context, to more 
accurately reflect current ideas with regards to cancer pain, its management and 
current pain management practice.  It consists of four factors namely, physiological 
effects, fatalism, communication and harmful effects and was shown to be a reliable 
and valid measure of cancer patients’ obstacles to pain management.   
Finally, the Pain Opioid Analgesic Beliefs Scale – Cancer (POABS-CA)[59] was 
designed in 2003 by Taiwanese researchers Liang et al to measure cancer patients’ 
beliefs in pain and opioid analgesics using 10 items on a 5-point Likert-type scale.  




The POABS-CA was also shown to possess satisfactory reliability and validity and 
consists of two factors: pain endurance beliefs and negative effect beliefs.  It was 
however validated only among Taiwanese cancer patients.  
 
Cancer Beliefs and Coping with Cancer 
Seven studies evaluated how cancer beliefs affected the ways in which patients coped 
with their cancer. Several of these studies involved a qualitative analysis. A large, 
fair-quality study (n = 1043) by Johannessen-Henry et al found that among cancer 
patients, greater spiritual beliefs and hence, greater spiritual well-being, was 
significantly related to having less distress (β=- 0.79, CI - 0.92; - 0.66), as well as 
better adjustment to a cancer diagnosis in terms of having greater fighting spirit, less 
anxious preoccupation, helplessness-hopelessness[60].  Doumit et al performed a 
qualitative study among Lebanese breast cancer patients and found that these women 
were generally subscribed to the belief that cancer was supernaturally derived, 
possessed the constant fear of recurrence of the illness and generally preferred support 
in the manner that revealed no discrimination towards them from people around 
them[61]. Another qualitative study, this time among Chinese women by Cheng et al, 
revealed that a combination of fatalistic belief and acceptance of the diagnosis 
together with a personal motivation for self-care were ways in which these Chinese 
women coped with a breast cancer diagnosis[62].  A study by Thuné-Boyle in the UK 
on early-stage breast cancer patients revealed that the perception of being punished 
and abandoned by God as the cause of having cancer contributed to feelings of 
anxiety but this was partially moderated in their coping process by acceptance of their 
illness[63].  In a qualitative study by Banning et al in Pakistan among Muslim breast 
cancer patients, it was found that this group of patients responded to chemotherapy 




with feelings of isolation and viewed it with aggression and anger[64].  Miccinesi et 
al performed a study among Italian cancer patients with the resultant findings[11]: a 
large proportion of Italian cancer patients have a personal spiritual life, with or 
without any religious affiliation.  Health care professionals were advised to be aware 
of, and to place more emphasis on the metaphysical assets of cancer patients.  
Alqaissi et al explored via phenomenological interviews that Jordanian breast cancer 
women rely heavily on other women for support, mainly within the family[65].  In 
addition, the research team recommended that health care professionals be aware of 
the influence of culture and religion, as well as clinical and individual characteristics 
of each woman on her requirements of social support. 
Johannessen et al employed the use of a series of questionnaires in their study, of 
which the Danish version of 12-item Functional Assessment of Chronic Illness 
Therapy-Spiritual Well-being (FACIT-Sp-12) was administered to measure spiritual 
well-being of patients.  It contains three domains on personal harmony, significance 
of self and personal belief. The Mini-MAC previously introduced was also used in 
this study to measure mental adjustment style following a cancer diagnosis.  
Miccinesi et al utilized the Systems of Belief Inventory (SBI-15R) to assess spiritual 
needs among Italian patients.  The SBI-15R contains a 10-item Beliefs subscale that 
assesses religious beliefs and participation in religious activities, and a 5-item Support 
subscale that assesses the support the patients received from the religious societies 
they belonged to. 
Thuné-Boyle et al utilized a number of questionnaires in their study.  The team used 
three single-item questions to assess cancer paitents’ beliefs in God, and the degree to 
which they perceived themselves as spiritual as well as the stability of their faiths.  
The authors also examined private religious or spiritual practices using three items 




from the “Multidimensional Measurement of Religiousness/ Spirituality for Use in 
Health Research: A Report by the Feltzer Institute/National Institute on Ageing 
Working Group”[66], with the items being rated on an 8-point Likert scale.  From the 
same report, the authors extracted and used two items to assess patients’ participation 
in religious practices and other religious activities with others.  Religious coping was 
assessed using three items with the highest loadings from RCOPE, a measure of the 
role of religion an individual employ in coping with stress in life.  The authors used a 
12-item sub-scale of spiritual involvement scale to assess patients’ private spiritual 
involvement.  This tool measures the degree to which patients privately assimilate 
their relationship with God and use it to cope with stress due to their cancer diagnosis.  
A 3-item tool was used to measure patients’ perceived spiritual support from God on 
a 5-point scale.  Non-religious coping was assessed using the Brief COPE, which 
consists of 14 items with 4-point scales.  The Life Orientation Test was utilized to 
measure patients’ optimism on a 5-point scale for the 8 items.  The three sources of 
emotional support as recognized by patients (friends, family and significant others) 
were examined by the Multidimensional Scale of Perceived Social Support.  This tool 
consists of 12 items on a 5-point scale, with higher scores showing greater perceived 
levels of social support.  
Banning et al used “semi-structured interviews” in an exploratory manner to elucidate 
Pakistani Muslim women’s perception of breast cancer, how they lived their lives 
upon diagnosis, as well as potential ways in which “cultural, socio-psychological or 
religious factors” may have affected their experiences.  However, there was no 
description of the questions asked during the interviews. 
 




Cancer Beliefs and Traditional/Complementary Medicine 
Three fair-quality studies showed popular use of CAM among cancer patients, 
ranging from 22.9% to 93.4% of those studied[67-69].  Many of these cancer patients’ 
beliefs about CAM included the belief that CAM could cure them of cancer[68] and 
that they were effective[67].   
In particular, Teng et al used a questionnaire that asked about patients’ use of 
CAM[67].  In this instrument, patients were asked to recognize a list of CAMs and 
whether they have used any in the course of their illness.  They were considered 
nonusers if they have not used any during their illness, even if they have previously 
used it before.  Further, users of CAM were asked on the frequency of CAM usage, 
where they procured the medications, expectations from usage of CAMs, actual 
beneficial effects derived from CAMs, any ill-effects felt from CAMs, and the costs 
of CAMs.   
Broom et al conducted a survey in Sri Lanka asking the cancer patients about their 
beliefs regarding CAM as well as their traditional medicine[68].  The survey 
consisted of reasons for using these traditional medicines and CAMs, as well as, 
reasons for not using them.  It also asked whether patients used these alternative 
treatments prior to seeking professional advice at a hospital.   
Takeda et al in Japan administered a self-report questionnaire to gynecologic cancer 
patients[69].  It consisted of three parts: general demographic information, an 8-item 
questionnaire about beliefs and attitudes about Japanese traditional medicine (Kampo) 
on a 5-point scale, and finally the third part is a Japanese version of the State-Trait 
Anxiety Inventory (STAI) which evaluates the level of anxiety of the patient at the 
point of answering the questionnaire and also the level of anxiety the patient normal 
felt. 





In this first systematic review of current knowledge landscape in patient’s cancer 
beliefs, we found that some of the studies focused on how cancer belief is associated 
with treatment acceptance and treatment adherence. The belief that use of CAM can 
“cure their cancer”[68] is one that prevail in many cultures and are not limited to non-
Western cultures. This myth appears to be particularly difficult to debunk despite 
considerable patient education effort.  The use of CAM is intimately linked to cultural 
practices of cancer patients.  In addition, the low incidences of adverse effects 
associated with CAM in comparison with Western medicine seem to affirm patients 
in their continued usage.  The inability of current technology in Western medicine to 
cure advanced cancers further erode patients’ faith.  As a result, patients may choose 
to instead rely on CAM.  As such, instead of seeking to abolish its practice, effort 
should perhaps be made to promote safer use of CAM, as well as encourage open 
discussion with their attending physicians when using CAM. 
There is a general lack of longitudinal studies that evaluate how interventions 
designed to alter cancer patient beliefs influence future health status or health 
behavior. There is a need for future research focusing on how negative beliefs about 
opioids and cancer treatments can be ameliorated. This study is important because 
acceptance and maintenance of treatment ensure that patients obtain the best possible 
outcomes in their cancer care management. 
Most of the studies were of fair quality. The best quality evidence we found were two 
large cohort studies with the rest being cross-sectional in design. There is clearly a 
need for good quality studies.  Randomized trials evaluating effects of interventions 
on cancer patients’ beliefs in terms of health outcomes may be challenging to 
conduct, but more malleable, large and well-designed controlled observation studies 




with proper assessment of and control for potential confounders could better clarify 
and even advance knowledge in this field.  In addition, we recommend that more 
qualitative studies should be performed to provide in-depth understanding of cancer 
patient beliefs. We have identified only a limited number of qualitative studies.   
We identified a total of eighteen questionnaires that measure patient belief about 
cancer (Table 1.3). All of these evaluate cancer patient beliefs related to medications. 
Among these questionnaires, only POABS-CA is opioid specific. This has great 
potential for use in other cultures. A well-designed instrument should have a sound 
theoretical basis and should be relevant to the target patient group.  In addition, it 
should possess good reliability and validity, and should be rigorously tested using 
relevant and current methodologies to justify its use.  In this light, the POABS-CA, 
which was validated only in the Taiwanese population, is deserving of further testing 
in other cultures. 
The Health Belief Model (HBM) proposed that an individual’s perceived 
susceptibility to a condition and his/her perceived severity of having that condition, 
coupled with the perceived benefits of reducing the risk or seriousness of the 
condition in spite of the perceived barriers to taking such actions, could help to 
explain or predict engagement in health-promoting behaviors[70]. Construct of self-
efficacy was added to the model to incorporate increasing evidence about its role in 
health behaviors and decision-making. From this review, we see that patients’ cancer 
beliefs affected various aspects of the management of their disease. Cancer patients’ 
negative beliefs about cancer treatments have been associated with low acceptance of 
recommended cancer management plans.  We have also found several studies that 
evaluated the association between cancer beliefs and health status or health behavior. 
These beliefs affect the way patients attribute the cause of their illness, which in turn 




affect how they went about addressing these believed attributions such as the adoption 
of healthier lifestyles for those who perceived exogenous factors to be contributing to 
their development of cancer.  The belief in supernatural causes may have affected 
some patients to become more anxious but it also led them to be more accepting of 
their illness. Thus, cancer beliefs are consistent with the HBM, with particular regard 
to a patient’s perception or beliefs of susceptibility, seriousness and barriers. This is 
explicitly manifest in the study on the development of the POABS-CA, whose results 
suggesting that negative opioid and cancer pain beliefs in cancer patients significantly 
determined their decisions on cancer pain management commensurate with the HBM, 
which assumes that a positive belief about illnesses and their treatments influenced 
people’s sustained investment in health improvement behaviors[71]. 
The theory of reasoned action (TRA) is another popular health behavior model.  The 
TRA strives to understand a person’s voluntary behavior with the goal to explain the 
relationship between the individual’s attitude and behavior in their actions[72]. 
Critical to this model are the individual’s “belief towards an outcome” and “beliefs of 
what others think”[73]. These translate to an individual’s attitude and subjective 
norm, respectively, which together contribute to behavioral intent[73]. Thus, a central 
theme of the TRA is an individual’s perception or “belief”, both on expected 
outcomes upon embarking on an improved health behavior as well as subjective 
norms with regards to such a health behavior. In this context, measuring cancer 
patients’ beliefs become particularly relevant when we are attempting to understand 
these individuals’ beliefs on expected outcomes of adhering to treatment such as 
chemotherapy or pain management plans, or how society and healthcare professionals 
(subject experts) perceive them using opioid analgesics for relief of cancer pain.  




However, a more pragmatic and current model that is a good fit with cancer beliefs is 
the theory of planned behavior (TPB)[74]. The TPB is an extension of the TRA to 
account for involuntary behaviors, since behavioral intent may not be the sole 
determinant of an individual’s behavior to take up a health intervention.  In addition, 
much like the updated HBM, it also includes self-efficacy as part of its model. This is 
especially consistent with cancer beliefs when an intervention to, for example, 
improve adherence to opioid pain medication is introduced to cancer patients. In 
addition to understanding patients’ negative beliefs about opioids, this model seeks to 
incorporate patients’ perceived behavioral control beliefs in adhering to their pain 
management regimen, thereby allowing us to better explain or predict the rates at 
which these interventions are successfully accepted and practised by patients. Since 
introducing a health intervention is a logical follow-up to discovering patients’ 
baseline beliefs, the TPB would seem to be a more consequential and relevant model 
to incorporate cancer beliefs. 
While it is beyond the scope of this review, it should be mentioned that there should 
perhaps be a specific cognitive framework for cancer patients, and this should be 
segregated between curative and palliative patients. The motivations behind patients 
undergoing curative treatments as opposed to those receiving palliative care are very 
different. Thus, intentions of receiving medical care between these two groups can be 
expected to be diverse as well. Especially pertaining to palliative care patients, 
comfort and palliation of cancer symptoms, as well as possible burdens to family, are 
chief concerns among their considerations in their care. As such, current existing 
theoretical frameworks related to health beliefs may not be fully relevant to this 
special group. Regnant sociocultural influences have harvested individuals that harbor 
a strong sense of familialism, wishing to leave a legacy for their family units, or those 




who are firmly entrenched in principlism. Or, more likely, many fall in the half-way 
point between these two extremes, hoping for assurances that their families will be 
adequately cared for and also for their own comfort in the dying process. Regardless 
of which camp one is invested in, a context-sensitive, patient-centered model to 
understanding palliative care patients’ decision-making phenomena should be used. 
Accomplishing this may require a modification of current TPB to include patients’ 
intentions on two subjects: internal (extents of comfort care), as well as external, 
(desire to leave a legacy). Future studies will be required to explore the feasibility of 
this cancer belief model for advanced cancer patients.    
An important strength of this review lies in the identification of the contexts in which 
studies related to cancer patients’ beliefs have been performed. This allows us to 
understand which aspects of cancer patients’ beliefs may have the greatest value for 
further study or are lacking in information and require more research to better 
examine its impact. In addition, we also described and appraised the content and 
psychometric properties of the measurement tools for assessing cancer patient beliefs.  
We are aware that there are limitations to our review. We have only included English-
language articles and excluded those published only as abstracts.  We could not assess 
publication bias because of the lack of evidence.  
 
1.5 Conclusion 
In summary, the impact of cancer patients’ beliefs has been studied in a variety of 
contexts but there is a general lack of well-designed studies. Several other contexts 
where cancer patient beliefs may play a role has not been explored and could be areas 
for future research.  
 












Eligibility Criteria Patient Characteristics Method for assessing 
outcomes and 
confounders 




Liang et al 2013 [7] Cross-
sectional; 
Taiwan 
4/0/2=6* Cancer patients with 
an average pain 
intensity score of 3 or 
more on a 0-10 scale 
in the past 24 hours; 
had been prescribed 
opioid analgesics for 
cancer-related pain 
on an around-the-
clock (ATC) and/or 
as needed (PRN) 
basis and had taken 
them for at least the 
past week; were 18 
years of age; and 
were conscious 
n = 92,  
Male (58.7%)  
Mean age = 56.4 years 
±12.2 (30 – 92)  
Majority of subjects 
(89.1%) 
lived with others 
(families/relatives/friends) 
Overall mean education 
level = 9.2 years±4.5 
POABS-CA Age, sex, living with 
others, education level 
Large numbers of patients had 
misconceptions about using opioids for 
pain.  
33.7% - 68.5% of the patients had 
negative beliefs about opioids and 
beliefs about pain, as quantified using 
the POABS-CA.  








Cancer patients with 
metastasis or 











n = 925,  
Mean age = 67±11 years, 
Men = 57%,  
ECOG 0 or 1 = 70%, 
Receiving treatment 
(chemotherapy or 
radiotherapy) = 60% 
 
Non-validated 
questionnaire on advanced 
cancer patients’ perception, 
knowledge as well as 
concerns about use of 
opioid painkillers, 
palliative care and 
homecare 
 
Knowledge about opioids, 
beliefs about palliative 
care, concerns about 
homecare, sense of security 
about cancer care, pain 
intensity, patient-perceived 
quality of pallaitive care 
 
Advanced cancer patients frequently 
had incorrect knowledge about opioids, 
a belief that palliative care is only for 
terminally ill patients, and concerns 
about homecare, especially the family 
burden and responses to sudden 
changes. 
 
Cohen et al 2008 [5] Cross-
sectional; 
Australia 
3/0/2=5* Cancer  patients older 
than 18 years who 
had been inpatients 
for a minimum of 48 
hours 
n = 126 
Median age (age in this 
study was not normally 
distributed) = 56.06 
years±15.98 
Males = 53.9% 
62.7% had 12 years of 
education or less. 
American Pain Society 
(APS) Patient 
Outcome Questionnaire 
Age, gender, education, 
cancer type, pain intensity, 
pain beliefs 
47.6% of patients had experienced 
moderate to severe pain in the previous 
24 hours but had only received 40.4% 
of available analgesic. Patients held 
varying beliefs about pain and pain 
treatments in particular, 41% held 
strong beliefs about the potential for 
addiction to narcotics. Patients who held 











Eligibility Criteria Patient Characteristics Method for assessing 
outcomes and 
confounders 
Variables adjusted for 
statistical analysis 
Primary results 
Solid tumors = 46% 
38% reported pain 
70.1% of those who 
reported pain had pain 
episodes in the 24 hours 
before interview 
this belief reported higher current pain, 
worst pain intensity, and higher average 
pain intensity in the previous 24 hours, 
even though they did not have any 
difference statistically in opioid usage 




Cancer Beliefs and Health Status or Health Behavior 
 





3/0/2=5* Jordanian women 
who had surgical 
treatment for early 
stage breast cancer 
(clinical stages 0-II) 
within 6 months of 
the interview, were 
18 years or older and 
were physically and 
mentally able to 
consent and 
participate in the 
study  
n = 28 
Mean age = 48.5 years  
(29 – 70) 
Majority were married, had 
high school education or 
less, with a diagnosis of 
stage II breast cancer, and 
had mastectomy as their 




phenomenology to uncover 
patients’ meaning of lived 
experiences via their 
narratives of their 
diagnoses and treatments, 
and the impact of 
sociocultural backgrounds 
on these aspects 
Quality of care at various 
health institutions, age, 
education 
Fear had a profound effect on Jordanian 
women’s stories of diagnosis and 
surgical treatment of early-stage breast 
cancer. 
Women’s experience with breast cancer 
and its treatment was shaped by their 
preexisting fear of breast cancer, the 
disparity in the quality of care at various 
healthcare institutions, and 
sociodemographic factors (e.g., 
education, age). When surgeons 
provided information and support, 
several of these patients made their own 
treatment choices. Lack of healthcare 
system support in Jordan did not 
prepare these women for and managing 
changes after treatment. 





 Cancer patients 
undergoing 
treatment, excluding 
terminally ill patients 
and those with other 
serious medical 
conditions 
n = 230 
Mean age = 46 years (13-
77) 
Females = 63% 
Married = 77.4% 
Formal education = 83% 
Bachelor degree = 33.5% 
Non-validated 
questionnaire asking 
current cultural practices, 
religious beliefs, education, 
employment status, 
previous treatment for 
disease, knowledge, beliefs 
and myths regarding risk 
factors for disease and its 
Various perceptions of 
cancer by patients 
Cancer was thought to be a contagious 
disease by 27.5% of patients.  
63.5% thought cancer is not related to 
any social habits like alcohol 
consumption. 
89.6% thought cancer was potentially 
curable. 60% believed rituals can bring 
about positive outcome.39.6% thought 
that regular religious activity can 











Eligibility Criteria Patient Characteristics Method for assessing 
outcomes and 
confounders 
Variables adjusted for 
statistical analysis 
Primary results 
treatment, role in decision 
making, satisfaction with 
provided knowledge and 
treatment 
prevent cancer. Only 39.6% were fully 
informed of their disease, treatment and 
side effects. 
Pakistani patients have unique beliefs in 
myths that physicians should be aware 
of 
        









(ADT) by injection, 
able to communicate 







n = 175,  
Mean age = 72.6 (51-90) 
years,  
Married = 80%,  
Retired = 68%,  
College or university 
education = 66%,  
Median duration of ADT = 
30 (1-221) months, 
Recevied bone mineral 
density (BMD) testing = 
38%.   
Based on BMD testing, 
46% had osteopenia and 
6% had osteoporosis 
 




(GLTEQ), 19-item form of 
the Facts on Osteoporosis 
Quiz-Revised (FOOQ), 
Osteoporosis Self-Efficacy 
Scale (OSES), and 




and health beliefs, healthy 
bone behaviors,  
 
Most patients who are receiving ADT 
are not receiving appropriate screening, 
lack basic information about bone 
health, and are not engaging in the 
appropriate healhy bone behaviors 
 
Ermiah et al. 2012[46] Cross-
sectional; 
Libya 
2/0/2=4* Breast cancer 
patients diagnosed 
during the period 
from Jan 1, 2008 to 
Dec 31, 2009. 
n = 200 
Mean age = 45.4 years 
(22–75).  
62% (n = 124) were 
literate.  




The data collection 
included social and 
demographic data, medical 
and obstetric history, 
symptom-related questions, 
and consultation-related 
questions. Dates of the 
chronological events (first 
recognition of symptoms, 
first consultation, referral 
and first hospital appoint- 
ment) were included. 
Diagnosis time and delays 
were estimated in days. 
Age, literacy, clinical 
staging at time of 
diagnosis, not considering 
symptoms as serious 
(patient’s perspective) 
The median of diagnosis time was 7.5 
months. Only 30.0% of patients were 
diagnosed within 3 months after 
symptoms. 14% of patients were 
diagnosed within 3– 6 months and 56% 
within a period longer than 6 months. 
Lord, K. 2012 [45] Cross-
sectional; 
4/0/2=6* Patients newly 
diagnosed with 
n = 279 (British South 
Asian, BSA = 94, British 
Hospital Anxiety and 
Depression Scale (HADS), 
Ethnicity, age, education, 
religion, cancer site, HADS 
232/279; 83.2% believed cancer was 
curable. However, significantly more 
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statistical analysis 
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UK cancer  
 
White, BW = 185) 
Median age for BSA = 
57.1 years ±19 
Median age for BW = 61 
years ± 14 
 
a version of the Patient 
Health Questionnaire 
(PHQ-9), which had been 
adapted and validated for 
use in India and translated 
into Gujarati and Hindi, 
Mini-Mental Adjustment to 
Cancer (MAC), Distress 
Thermometer, Cancer 
Insight and Denial, and 




And a non-validated tool 
on patients’ views on 
confidentiality, outcome 
and cancer treatment and 
beliefs about the causes of 
cancer. 
subscales, type of treatment BSA (10.6% versus 2.7% BW P < 
0.001) believed cancer was incurable. 
While 86.4% agreed that smoking can 
cause cancer, there was a widespread 
lack of knowledge of the importance of 
diet and obesity as contributing causes 
of cancer. 
There was a strong belief in 
supernatural involvement in the 
development of cancer among a 
minority of BSA patients.  
20% of this sample believed that 
treatment, especially surgery, caused the 
cancer to spread and this was associated 
with significant depression in BSAs (P 
= 0.019) and anxiety in both BW (P = 
0.006) and BSA (P = 0.0134) patients. 
 
Panjari, M. 2012 [41] Cohort 
study; 
Australia 
3/1/2=6* Women were 
recruited within 12 





n = 1489 
43.5% (647/1489)  of 
women answered “Yes” 
when asked if they 
believed their cancers to be 
attributable to a cause. 
They were more likely to 
be younger than women 
who did not report a 
specific contributing factor 
to their breast cancer 
(mean age = 56.6 years ± 
11.2 versus 
61.2 years± 12.2, 
p<0.0001) and educated 
beyond 










treatments, general medical 
conditions, partnership 
status and body image.  
Age, likelihood of reporting 
a belief in a reason for 
breast cancer, education, 
being at > stage 1 at 
diagnosis, reporting stress 
as reason for developing 
breast cancer, PGWB total 
score 
Stress (58.1%) was the most common 
reason. 
Many women with breast cancer believe 
that stress has contributed to their 
condition and they had lower PGWB 
scores than other study participants 
(70.9±16.1, n=361 versus 77.3± 14.9, 
n=1071, mean difference=6.4, 95% CI: 
4.6–8.2 p<0.0001) 
Women who held this belief were more 
likely to adopt strategies to reduce stress 
than those who did not. 




3/0/2=5* Stages 0-III breast 
cancer patients who 
n = 71 
Median age = 55.0 years 
Non-validated 
questionnaire and Illness 
Age and duration of 
treatments 
Survivors reported behavior changes 
directed toward improving physical, 
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USA were treated with 
adjuvant 
chemotherapy and/or 




Revised (IPQ-R). Patients 
post adjuvant 
chemotherapy and/or 
radiotherapy were assessed 
for changes in health 
practices and other 
behaviors, as well as  
beliefs about the causes, 
course, personal control, 
and consequences of their 
cancer 
emotional, and spiritual well-being.  
Those who believed their cancer had 
more severe consequences and those 
who attributed the development of 
cancer or the prevention of recurrence to 
health behaviors or stress were most 
likely to report improvement in diet or 
physical activity and reduction in 
alcohol use or stress. 





5/0/2=7* Cancer patients 




n = 72 
Mean age = 55 years (22-
83) 
Female = 54% 
Married = 61% 
Education = 43% 
preschool leaving 




Hospital Anxiety and 
Depression (HAD) 
Scale 
Age, gender, no. of 
treatments, new or relapsed 
cancer, no of symptoms 
reported, mean perceived 
symptom severity, no. of 
symptoms attributed to 
treatment, consequence 
beliefs 
Consequence beliefs serve as important 
mediators between number of 
symptoms and distress, explaining 15% 
of the variance in anxious mood and 5% 
of the variance in depressed mood.  
Perceived severity of symptoms is an 
independent predictor of anxious mood, 
explaining 7% of the variance. Its role 
in predicting depressed mood was not 
significant. 





5/0/2=7* Cancer patients who 
had completed 
treatment for cervical 
or endometrial cancer 
5 or more years 
previously 
n = 134 
Mean age = 60 years (23-
90) 
White ethnicity = 95% 
Married = 51% 
High school education = 
40% 
Employed = 47% 
Functional Assessment 
of Cancer Therapy (FACT) 
version 3, Center for 
Epidemiological Studies 
Depression Scale (CES-D), 
Impact of Events Scale 
(IES), Concerns About 
Recurrence Scale (CARS) 
Age, cancer site, stage, 
treatment received, years 
since diagnosis, current 




Genetics/heredity was rated as the most 
important cancer cause, followed by 
stress, God’s will, hormones, and 
environmental factors. Medical 
screening was rated as most important 
in preventing recurrence, followed by 
positive attitude and prayer. Stronger 
causal attributions were generally 
associated with elevated depressive 
symptomatology and anxiety, but 
women citing potentially controllable 
causes were more likely to be practicing 
healthy behaviors.  
Similarly, women citing health 
behaviors as important in preventing 
recurrence reported greater anxiety but 
were more likely to practice positive 
health behaviors.  
Health behavior and lifestyle 
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outcomes and 
confounders 
Variables adjusted for 
statistical analysis 
Primary results 
attributions interacted with health 
practices in predicting distress. For 
example, among women who had not 
made positive dietary changes, rating 
lifestyle as important in preventing 
recurrence was associated with greater 
distress, whereas among women who 
had made a positive change in diet, this 
belief was associated with less distress. 
 
Cancer Beliefs and Treatment Adherence 
 
Liang et al 2013 [24] Cross-
sectional; 
Taiwan 
3/0/2=5* Cancer patients with 
an average pain 
intensity score of 3 or 
more on a 0-10 scale 
in the past 24 hours; 
had been prescribed 
opioid analgesics for 
cancer-related pain 
on an around-the-
clock (ATC) and/or 
as needed (PRN) 
basis and had taken 
them for at least the 
past week; were 18 
years of age; and  
were conscious 
n = 92, male (58.7%)  
Mean age = 56.4 years 
±12.2 (30 – 92)  
Majority of subjects 
(89.1%) 
lived with others 
(families/relatives/friends) 
Overall mean education 
level = 9.2 years±4.5 
POABS-CA Age, sex, living with 
others, education level 
Beliefs about pain and opioids 
demonstrated a significant relationship 
with patients’ opioid adherence (r = -
0.30, p < 0.01).  
However, no significant correlation 
between opioid belief and pain 
experience was found. 
There were also no significant 
relationships between adherence to 
opioid regimen and any of the measures 
of pain experience. 








diagnosed with stage 
I-III colorectal 
cancer; patients not 




n = 601 (1-year interview), 
n = 277 (4-year follow-up), 
Female 53% (based on 4-
year follow-up),  
Age < 65 = 52%, 
Education high school or 
more = 49%,  
Insured = 84% 
 
Interview based on Health 
Belief Model (HBM) 
 
Intention to undergo 
coloscopy, health beliefs in 
terms of likelihood of 
getting colorectal cancer 
again, perceived barriers 
and benefits to coloscopy, 
self-efficacy and any 
physician recommendation 
for colonoscopy; screening 
history, age , sex, 
Greater perceived susceptibility to 
colorectal cancer (OR=2.00, 95% 
CI=1.16–3.44) among these patients 
was associated with greater motivation 
to have a colonoscopy. Survivors who 
already had a colonoscopy since 
diagnosis also had greater intentions of 
having a colonoscopy in the future 
(OR=9.47, 95% CI=2.08–43.16). 
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Valeberg et al 2008 [75] Cross-
sectional; 
Norway 
4/0/2=6* Cancer patients 
over18 years of age, 
had self-reported 
pain of any intensity 
and/or use of 
analgesics; and  
were able to read, 
write, and understand 
Norwegian. 
n = 174 
Females = 79% 
Mean age = 58 years ±11.4 
Had college or university 
education = 35% 
Married = 70% 
Not working = 84% 
Most common diagnosis = 
breast cancer (42%) 
Metastatic cancer = 43% 




adherence and self-efficacy  
Age, gender, education, 
clinical and pain 
characteristics, levels of 
adherence 
41% of the patients were adherent with 
their analgesic regimen.  
In the regression analysis, 29.9% of the 
variance in adherence was explained.  
Higher adherence scores were 
associated with male sex, and also lower 
SE for physical function scores, higher 
average pain intensity scores, higher 
pain relief scores, and the use of strong 
opioid analgesics. 





4/0/2=6* Women aged 35–65 
years who were in 
remission from 
primary breast cancer 




n = 110 
Mean age 56.3 years ±7.0 
(38-65) 
White ethnicity = 93% 
Married or cohabiting = 
67% 
Employed = 44% 
Mean time taking 
tamoxifen = 2 years 9 
months±1 year 7 months 
Women’s Health 
Questionnaire (WHQ), 
Beliefs about medicines 
questionnaire (BMQ), 
Medication Adherence 
Report Scale (MARS-5), 
non-validated single 
question ‘‘In the past week 
have you taken your,  
tamoxifen every day?’’, 
non-validated hot flushes 
and night sweats 
questionnaire 
Age, individual 
components of MARS-5, 
necessity, concerns, 
overuse and harms subscale 
of BMQ, MARS-5 scores,  
Non-adherers were more likely to report 
a belief that there was nothing to be 
gained from taking tamoxifen whereas 
adherers were more likely 
to report that tamoxifen would stop 
them from developing breast cancer.  
Main reason for not taking tamoxifen 
was side effects.  
No differences between adherers and 
non-adherers with regard to the 
strategies used to remember to take 
tamoxifen or with regard to the time of 
day tamoxifen was taken. 





2/0/2=4* Breast cancer 
patients over 18 years 
of age and were 
scheduled for breast 
and lymph node 
surgery 
n = 98 
Mean age = 55.3 years 
±10.6 
Married or partnered = 
70.5% 





were surveyed regarding 
utilization rates, health 
beliefs, and medical and 
demographic 
characteristics, using a 
questionnaire constructed 
based on the Health Belief 
Model. 
Age, lymphedema-related 
knowledge and trait anxiety 
Levels of adherence to risk management 
strategies were moderate (M=9.53, 
SD=2.95; 
range 0–12), and knowledge was high 
(M= 9.53, SD= 2.95).  
Perceived consequences, controllability, 
self-efficacy and self-regulatory ability 
subscales were significantly positively 
correlated with adherence.  
Trait anxiety (r =_0.27, p = 0.009) and 
knowledge (r=0.29, p = 0.005) were 
significantly associated with adherence; 
hence, both variables were treated as 
covariates in analyses.  
Demographic, medical status, family 
breast cancer history and family/friend 
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Variables adjusted for 
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Primary results 
lymphedema history variables were not 
associated with adherence. 
Greater adherence was associated 
bivariately with greater beliefs in 
lymphedema controllability, self-
efficacy, perceived consequences and 
perceived self-regulatory ability.  
Linear regression analyses revealed that 
greater beliefs in the controllability of 
lymphedema and self-regulatory ability, 
as well as greater knowledge, were 
predictive of greater adherence to risk 
management strategies. 
Saratsiotou, I. 2011 [51] Cross-
sectional; 
Greece 
3/0/2=5* Patients on oral 
chemotherapy. 
n = 99 
Median age = 61 years (30-
91) 
Female = 62 
Most common tumor type 
was breast cancer. 
Non –validated 
questionnaire, asking 
patients on their treatment 
profiles, attitudes about 
oral chemotherapy, 
whether they were 
adherent, whether they 
were intentionally 
nonadherent, and 
suggestions to improve 
adherence 
Treatment profile, type of 
drug, age, sex, education, 
tumor type, adherence, 
nonadherence, causes of 
unintentional nonadherence 
Greek patients have similar non-
adherence pattern as in other countries. 
Confidence in treatment efficacy 
appeared as a significant adherence 
determinant. 





4/2/3=9* All patients 




1976 and 2003, who 
survived for 5 years 
or more 
n = 1075 
Median age at study = 26.3 
years (19-49) 
Median age at diagnosis = 
8.5 years (0-16) 
Median time since 
diagnosis = 19.5 years (6-
36) 
Swiss Census questionnaire 
for demographics and non-





More survivors at high risk of cancer- 
and treatment-related late effects attend 
follow-up care in Switzerland.  
Patient-perceived barriers hinder 
attendance even after accounting for 
medical variables. 
Cancer Beliefs and Coping with Cancer 
 
Banning et al. 2009 [64] Cross-
sectional; 
Pakistan 
3/0/1=4* Breast cancer 
patients at age range 
of 22 to 60 years, 
receipt of treatment 
as a hospital inpatient 
for breast cancer, of 
Muslim belief and 
n = 30 
3 were single, 2 widows, 2 
living separate from 
husbands, 1’s husband had 
second wife, 22 living with 
husbands. 
Married woman have 
Non-validated 
questionnaire, where 
patients were asked, via a 
self-reported 7-page 
questionnaire about their 
demographic profile, 
disease and treat- ment 
No statistical analysis 
performed in the study 
(qualitative design) 
The data not only highlight the role of 
religion and family support as essential 
coping strategies but also emphasize the 
issues of isolation, aggression, and 
anger as common responses to 
chemotherapy. 
Unique features of this study are 
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Pakistani origin average of 3 children (2-5). 
Most were housewives. 
characteristics, and side-




women’s need to seek spiritual support 
for their illness and the overriding 
innate characteristic of maternal 
responsibility 





5/0/2=7* Newly diagnosed 
breast cancer patients 
with 
subsequent surgery  
n = 140 with early stage (I 
& II) breast cancer. 
 






Spirituality for Use in 
Health Research: A Report 
by the Feltzer 
Institute/National Institute 
on Ageing Working Group, 
spiritual 
involvement scale, spiritual 
support scale, Life 
Orientation Test, 
Multidimensional Scale of 
Perceived Social Support, 
Hospital Anxiety and 
Depression Scale 
Religious/Spiritual 
variables, age, type of 
surgery, whether 
patients had had a 
reconstruction or not, 
feeling 
punished and abandoned by 
God, optimism, denial, 
self-blame and venting 
‘Feeling punished and abandoned by 
God’ significantly explained 5% of the 
variance 
in increased levels of anxiety but was 
partially mediated by denial coping. I 
t was partially mediated by acceptance 
coping, lowering levels of anxiety.  
Feeling punished and abandoned by 
God was a significant independent 
predictor of depressed mood, explaining 
4% of the variance. 











n = 252,  
Mean age = 53.6 (±12.2) 
years,  
Females = 74%,  
Believers and church-goers 
= 49%,  
Believers but not church-
goers = 43%,  
Non-believers = 8% 
 
Systems of Belief 
Inventory (SBI-15R) 
 
SBI-15R items as measure 
of spirituality, belief status 
 
A large proportion of Italian cancer 
patients have a personal spiritual life, 
with or without any religious affiliation.  
Health care professionals may wish to 
pay more attention to spiritual resources 
for cancer patients. 
 








diagnosed with Stage 
I to III cancer and are 
completing their 
treatments or have 
completed their 
n = 20,  
Mean age = 45.8 (±7.3) 
years,  
Mean years of formal 




interview on the meaning 
of social support for 
Jordanian women with 
breast cancer 
 
No statical analysis 
performed 
 
Jordanian breast cancer women rely 
heavily on other women for support, 
mainly within the family.   
Health care professionals need to be 
aware of influence of culture, religion, 
as well as clinical and personal 
characterristics of each woman on her 
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requirements of social support 
 
Johannessen-Henry, C. 




5/0/2=7* Adult cancer patients 





participating in the 
physical activities 
offered and who had 
an expected survival 
of at least six months 
n = 1043 
Women = 76%,  
Mean age = 58 years (10-
90% range, 43-72 years). 
Most were diagnosed with 
cancer of the breast, 
colorectum, female genital 
organs or prostate. 
Generally, the participants 
had higher education 
(515), and most were 
working (57%) and living 
with a partner (68%) at the 
time of enrolment into the 
study.  
Most were members of the 
Evangelical Lutheran 
Church (83%), but only 
3% attended services 
weekly.  
60% of the participants, 
mostly women, 
characterized themselves 
as believing in a god 
Danish versions of 
Functional Assessment of 
Chronic Illness Therapy — 
Spiritual Well-being 12 
items [FACIT-Sp-12 
(version 4)], Profile of 




Assessment of Cancer 
Therapy — General 
(FACT-G, version 4) 
Faith, distress, mental 
adjustment to cancer, 
gender, age and cancer 
diagnosis, social and 
physical well-being 
Higher spiritual well-being was 
associated with less total distress ( β=- 
0.79, CI - 0.92; - 0.66) and increased 
adjustment to cancer (fighting spirit, 
anxious preoccupation, helplessness-
hopelessness). 
Specific aspects of faith were associated 
with high confusion-bewilderment and 
tension-anxiety, but also lower score on 
vigor-activity, and with higher anxious-
preoccupation, both higher and lower 
cognitive avoidance, but also more 
fighting spirit. 
 





3/0/2=5* 18 years or older, 
with a first diagnosis 
of breast cancer; had 
completed surgery 
and systematic 
treatments; and were 
able to communicate 
in Mandarin. 
n = 29 
25 were married or had a 
partner, and their ages 
ranged from 41 to 69 years 
(mean, 53.9 years ± 7.24). 
 
Non-validated 
questionnaire on breast 
cancer patients’ experience 
of survivorship which 
explored the role of 
fatalism in coping with the 
disease experience 
Qualitative study, only 
descriptive statistics 
Median length of survivorship since the 
completion of treatment for these study 
participants was 45months (interquartile 
range, 23-60 months); 62.1% were 
diagnosed at stage II.  
All participants received either modified 
radical mastectomy or radical 
mastectomy and completed 
chemotherapy. 
Findings suggest that fatalism related to 
coping in the Chinese context combined 
2 elements: fatalistic belief in and 
acceptance of the way things are as well 
as the exertion of personal efforts over 
the situation.  
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Doumit et al 2010 [61] Cross-
sectional; 
Lebanon 
3/0/1=4* Lebanese Arabic 
speaking stage I-III 
breast cancer patients 
living in Lebanon at 
an age of 25 years or 
older, without distant 
metastases, previous 
history of mental 
disorders, or the 
existence of other 
forms of cancer or 
other chronic 
diseases and agreed 
to be interviewed 
without the presence 
of a third person to 
ensure liberty 
for the participant to 
express her feelings 
n = 10 
Mean age = 51.3 years (36-
63) 
Patients’ experience with 
breast cancer ranged = 4 
months to 9 years. 
8 remained married, 2 
widowed. 
Non-validated 
questionnaire using a 
phenomenological 
approach to study how 
breast cancer patients cope 
with with disease 
Statistical analysis not done 
in study 
The negative stigma of cancer in the 
Lebanese culture, the role of women in 
the Lebanese families, and the 
embedded role of religion in Lebanese 
society are bases of the differences in 
the coping strategies of Lebanese 
women with breast cancer as compared 
to women with breast cancer from other 
cultures. 
 
Cancer Beliefs and Traditional/Complementary Medicine 
Takeda, T. 2012 [69] Cross-
sectional; 
Japan 
3/0/2=5* Gynecologic cancer 
patients who were 
treated and followed 
at Tohoku University 
Hospital in Sendai, 
Japan 
n = 420  
Median age = 53 (19=76) 
96 (22.9%) Kampo users 




consisted of general profile 
factors such as 
demographics, usage of 
traditional Kampo and 
dietary supplements, side 
effects of western treatment 
and beliefs and attitudes 
about Kampo. 
Age, time from diagnosis to 
screening, cancer site, 
treatment, dietary 
supplements, side effects of 
treatment, satisfaction with 
conventional treatment, 
state anxiety, trait anxiety 
Kampo users made more favorable 
comments on Kampo medicine than 
nonusers.  
Psychological characteristics of 
individual patients is one of the factors 
that can influence the usage of Kampo. 
Broom, A. 2010 [68] Cross-
sectional; 
Sri Lanka 
4/0/2=6* Cancer patients who 
were currently 
undergoing or had 
previously received 
cancer treatment  
n = 500 
Female = 53% 
Average age = 45.6 ±15.4 
years 
Non-validated 
questionnaire that asked 
patients on use of 
traditional medicine and 
reasons for using them. 
Gender, marital status, 
religion, area of Sri Lanka, 
cancer site, treatment, time 
since diagnosis 
67.4% of those surveyed used one or 
more TCAM in conjunction with 
biomedicine for cancer treatment. 
The most common were Sinhala, 
Ayurveda and traditional religious 
practices. Of those patients who used 
TCAM, 95.0% gave the main reason for 
usage as ‘they thought it would cure 
their cancer’.  
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The strongest reason for not using 
TCAM was on advice from their doctor 
(80.5%). 
 
Teng et al. 2010 [67]  Cross-
sectional; 
China 
3/0/2=5* Adult cancer patients 
who were aware of 
their diagnosis, able 
to understand the 
questions, were free 
from any condition 




overburdening for the 
patients 
n = 121 
Males = 64 (52.9%) 




questionnaire that asked 
patients on use of 
complementary medicine, 
their level of satisfaction 
using them and the benefits 
derived. 
Age, marital status, 
socioeconomic status, 
educational level, 




93.4% used CAM at some point during 
their cancer illness (of these 54.0% were 
male). 
Over 71.7% of those who used CAM 
were satisfied, only 28.3% were 
disappointed.  
Twenty-eight users (24.8%) did not see 
any benefit from the CAM, but eighty-
one patients (71.7%) could describe 
some specific benefits. Only one patient 
will use orthodox medicine instead of 
CAM in the future, almost all patients 









Table 1.3 - Questionnaires used to measure patients’ beliefs 
 






Scale – Cancer 
(POABS-CA)[59] 
 
2003 Taiwan 10 items to assess cancer patients’ beliefs about opioid analgesics Yes Cronbach’s alpha = 0.70 
Cohen’s kappa = NA 
Test-retest = 0.94 
Factor structure = confirmed 
Known group validity = supported 
Convergent validity = NA 
Divergent validity = NA 
Face validity = supported 
Concurrent validity = NA 
Predictive validity = NA 
Beliefs in Medicines 
Questionnaire 
(BMQ)[56] 
1999 UK Two sections (18 items): 
1) BMQ-Specific (two parts): 
a) Specific-Necessity (5 items):  
- assesses beliefs about the necessity of prescribed medication 
b) Specific-Concern (5 items): 
- assesses beliefs about concerns about prescribed medication based on 
beliefs about dangers of dependence and long-term toxicity and the 
disruptive effects of medication 
2) BMQ-General (two parts): 
 a) General-Harm (4 items): 
- assesses beliefs that medicines are harmful, addictive poisons which 
should not be taken continuously 
b) General-Overuse (4 items): 
- assesses beliefs that medicines are overused by doctors 
These two sections can be used separately or in combination. 
 
No Specific-Necessity 
Cronbach’s alpha = 
performed across 6 chronic 
diseas groups 
Cohen’s kappa = NA 
Specific-Concern 
Cronbach’s alpha = 
performed across 6 chronic 
diseas groups 
Cohen’s kappa = NA 
General-Harm  
Cronbach’s alpha = 
performed across 6 chronic 
diseas groups 
Cohen’s kappa = NA 
General-Overuse 
Cronbach’s alpha = 
performed across 6 chronic 
diseas groups 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = confirmed 
Known group validity = supported 
Convergent validity = NA 
Divergent validity = supported 
Face validity = NA 
Concurrent validity = NA 
Predictive validity = NA 
Akiyama et al [27] 2012 Japan To study advanced cancer patients’ perception, knowledge as well as 
concerns about use of opioid painkillers, palliative care and homecare 
Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 
Predictive validity = NA 
Kumar et al [48] 2010 Pakistan A set of questionnaires that examined themes of current cultural practices and 
religious beliefs, and also included patient-level information on education 
levels, employment statuses, as well as knowledge and beliefs regarding 
cancer risk and treatments. 
Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 








Face validity = NA 
Concurrent validity = NA 





1994 UK To measure the coping styles that cancer patients have when diagnosed with 
the disease with 29 items 
Yes Cronbach’s alpha = 0.51 to 
0.79 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = confirmed 
Known group validity = supported 
Convergent validity = supported 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = supported 
Predictive validity = NA 
Physician/Patient 
Trust and Cancer 
Beliefs [45] 
2012 UK To assess patient’s opinions on confidentiality outcome and cancer 
management 
Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 




1991 USA To measure health beliefs in the domains of perceived osteoporosis 
susceptibility, seriousness about osteoporosis and general motivation to health 
No Cronbach’s alpha = 0.61 to 
0.80 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = confirmed 
Known group validity = supported 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = supported 
Predictive validity = NA 
Costanzo et al [42] 2005 USA To understand patients’ cancer cause attribution and prevention of recurrence Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 




2003 USA To assess the extent and nature of women’s fears about possibility of 
recurrence of breast cancer 
Yes Cronbach’s alpha = 0.89 to 
0.94 among four subscales 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = confirmed 
Known group validity = NA 
Convergent validity = supported 
Divergent validity = NA 
Face validity = supported 
Concurrent validity = NA 






To measure cancer patients’ beliefs about the potential for cure of the disease, 
as well as the ramifications of cancer and its management. 
 
Yes Cronbach’s alpha = 0.73 to 
0.82 
Cohen’s kappa = NA 
Factor structure = NA 
Known group validity = supported 
Convergent validity = NA 








Test-retest = 0.49 to 0.84 Divergent validity = NA 
Face validity = NA 
Concurrent validity = supported 
Predictive validity = supported 
Michel et al [33] 2011 Switzerland Measures of perceived susceptibility to late effects of past cancer treatments 
on a 10cm visual analogue scale, perceived benefits and barriers to follow-up 
care, importance of health to the individual and beliefs on detecting and 
treating late effects of cancer treatments early 
Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 
Predictive validity = NA 
Sarasiotou et al [51] 2011 Greece To measure belief in objective of oral chemotherapy Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 







2013 Denmark To assess the spiritual well-being of patients Yes Cronbach’s alpha = 0.81 to 
0.88 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = confirmed 
Known group validity = NA 
Convergent validity = supported 
Divergent validity = supported 
Face validity = supported 
Concurrent validity = supported 
Predictive validity = NA 
Systems of Belief 
Inventory (SBI-15R) 
[81] 
1998 Italy To assess spiritual needs among Italian patients: 
- Beliefs subscale has 10 items that assess religious beliefs and participation 
in religious activities 
- Support subscale has 5 items to assess the support the patients received from 
the religious societies they belonged to 
Yes Cronbach’s alpha = 0.93 
overall and 0.92 and 0.89 
for Beliefs and Practices 
Subscale and Social 
Support Subscale, 
respectively 
Cohen’s kappa = NA 
Test-retest = 0.95 
Factor structure = confirmed 
Known group validity = supported 
Convergent validity = supported 
Divergent validity = supported 
Face validity = NA 
Concurrent validity = NA 
Predictive validity = NA 
Thuné-Boyle et al 
[63] 
2013 UK A set of questionnaires: 
- three single-item questions to assess cancer paitents’ beliefs in God, and the 
degree to which they perceived themselves as spiritual as well as the stability 
of their faiths 
- a 12-item sub-scale of spiritual involvement scale to assess patients’ private 
spiritual involvement which measures the degree to which patients privately 
assimilate their relationship with God and use it to cope with stress due to 
their cancer diagnosis 
Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 
Predictive validity = NA 








- a 3-item tool was used to measure patients’ perceived spiritual support from 
God on a 5-point scale 
Teng et al [67] 2010 China To measure expectations from use of CAM Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 
Predictive validity = NA 
Broom et al [68] 2010 Sri Lanka To measure cancer patients about their beliefs regarding CAM as well as their 
traditional medicine 
Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 
Predictive validity = NA 
Takeda et al [69] 2012 Japan An 8-item questionnaire about beliefs and attitudes about Japanese traditional 
medicine (Kampo) on a 5-point scale 
Yes Cronbach’s alpha = NA 
Cohen’s kappa = NA 
Test-retest = NA 
Factor structure = NA 
Known group validity = NA 
Convergent validity = NA 
Divergent validity = NA 
Face validity = NA 
Concurrent validity = NA 





2002 USA Update of BQ to more accurately reflect current ideas with regards to cancer 
pain, its management and current pain management practice. 
Yes Cronbach’s alpha = 0.89 
overall and 0.75 to 0.85 for 
the four subscales 
Cohen’s kappa = NA 
Test-retest = NA (only 
done for original BQ, 
ranging 0.53 to 0.90) 
Factor structure = confirmed 
Known group validity = supported 
Convergent validity = supported 
Divergent validity = NA 
Face validity = supported 
Concurrent validity = NA 
Predictive validity = NA 
 
 









Chapter 2. Prevalence data on opioid consumption patterns in NCCS  
  





The International Association for the Study of Pain announced in its Declaration of 
Montreal[83] that a patient’s access to medications for the relief of pain is an 
elementary human right.  Further, the autonomous authorities that practice United 
Nations drug rules, the World Health Organization (WHO) and International 
Narcotics Control Board (INCB), have untiringly advocated that various controlled 
drugs are necessary analgesics in the treatment of many ailments.  It was not 
coincidence that there was a notable sustained increase in use of opioids in the world, 
where prior to 1987 use of opioids were below Global Morphine Equivalent (ME) of 
5mg/capita, to beyond 45mg/capita in 2011[84].  In the United States itself, as the 
largest consumer of opioids in the Regional Office for the Americas (AMRO) which 
in turn far surpasses all other WHO regions, a 1448% increase in medical use of 
opioids was seen between 1996 and 2011, and this was accompanied by an even more 
dramatic increase in opioid abuse (4680%) as well[85]. 
Age-adjusted rate for opioid-analgesic related deaths in the United States was 
reported to have almost quadrupled from 1.4/100,000 in 1999 to 5.4/100,000 in 
2011[86].  In Australia, although morphine use declined while oxycodone use 
increased, number of treatments for morphine poisoning maintained while that for 
oxycodone expectedly increased between 2001 and 2009[87]. 
While INCB provides national-level data on opioid usage, this collective information 
includes both cancer and non-cancer use.  While opioids are widely accepted as 
treatment for cancer pain, their use in non-cancer treatments is more controversial: the 
risk of opioid misuse, abuse and diversion in the treatment of non-cancer pain is a 
potential problem[88].  Non-adherence patterns from these two groups of patients can 
be quite different: cancer patients tend to refuse opioids[24] while non-cancer patients 




may use more than is prescribed for them[88].  Thus, due to these different groups of 
patients having potentially different profiles of non-adherence, it is imperative to our 
interest to acquire opioid usage patterns for cancer-use only. 
 
Opioids are categorized according to their strengths.  Weak opioids such as codeine 
and tramadol are differentiated from stronger opioids such as morphine and 
oxycodone.  The stronger the opioid, the greater its potency as a central nervous 
system (CNS) depressant and a consequent higher risk of lethal toxicity if 
recommended doses are exceeded, especially in combination with other CNS 
depressants such as alcohol or benzodiazepines[89].  Hence, an increase in prevalence 
of use of stronger opioids would be of concern. 
 
A study in Canada found consistent correlations between increased use of prescription 
opioid analgesics and mortality, particularly strong opioids such as hydromorphone 
and oxycodone[90]. 
In addition, there are associations between prescribing of strong opioids such as 
oxycodone and non-medical use as well as emergency department (ED) visits in 
USA[91].  Thus, increasing the availability and consumption of strong opioids raise 
the likelihood of harms: as more individuals have exposure to opioid analgesics, more 
people may develop dependence to opioids and possibly look for more opioids for 
diversion or abuse[92].  Mortality due to overdose of opioids have also seen a surge in 
USA alongside an increase in opioid doses prescribed[93]. 
These problems can be expected to be potentiated in strong opioids such as 
oxycodone.  Case in point, oxycodone-related death was found to increase 21-fold 




over 10 years in Victoria, Australia, and is associated with an increased supply of the 
specific opioid[89]. 
 
The objective of this study is to acquire trend of opioid usage in a local ambulatory 
cancer center to obtain baseline understanding of our opioid consumption. Should the 
results of this study be similar to trends experienced in Australia and United States, 
this will in turn  allow decision makers to anticipate associated harms with increased 
consumption of opioids and to allow potential future mitigation by increasing 
emphasis on the understanding of patients’ adherence to opioids. 
 
2.2 Methods 
The study will be conducted in an ambulatory cancer centre in NCCS using 5-year 
consumption data (Jan 2010-Dec 2014) from MaxCare®, an institution-wide 
dispensing software used by NCCS pharmacy. 
Inclusion criteria are all dispensed opioids from NCCS during the eligible period (Jan 
2010-Dec 2014). These are: codeine, tramadol, morphine, fentanyl and oxycodone. 
Samples of opioids will not be excluded. 
The MaxCare® program was used to generate a list of opioids dispensed from NCCS 
in period stipulated (Jan 2010 – Dec 2014) from its transaction history.  These were 
segregated as different opioids in its various dosage forms, in chronological order. 
Opioid use was not differentiated between as-needed and around-the-clock usage. 
 
Data cross checking 
Total cost of each opioid was present in the report. The total quantity of each opioid 
was summed and then multiplied by its unit cost.  This information is cross-checked 




against the total cost of each opioid to ensure that quantity of each opioid was 
accurately tabulated.  If total costs derived do not match the total costs stated for each 
opioid, a mistake must have occurred in tabulating the quantities. 
Morphine equivalents 
Each opioid’s strength was divided by its corresponding equivalent morphine strength 
to obtain morphine equivalents (ME).  Using ME allows us to equate different opioids 
and their varying potencies into a standard morphine equivalent value.  A high ME is 
an indicator of a strong opioid. 
As MaxCare® only codes opioids by their generic names, trades names were not 
used. 
Data analysis will be presented in the form of a line chart of opioid use (morphine 
equivalents on the y-axis vs the years 2010-2014 on the x-axis) in NCCS.   
 
2.3 Results 
The study results are summarized in line charts as Figure 2.   
The numbers of patients prescribed opioids over the years of 2010 to 2014 were as 
follows: 5766, 6840, 6230, 6275 and 6241. 
From 2010 to 2014, a general decline was seen for both codeine and morphine. 
Fentanyl use was observed to increase from 2010 and then decline over 2014. Use of 
oxycodone and tramadol saw a steady increase from 2012 to 2014. 
 
2.4 Discussion 
Although cancer diagnoses in Singapore rose over the years, use of opioids remained 
stable.  Despite more cancer diagnoses in 2014, there was a decrease in opioid usage 
compared to in 2011, which could be due to greater awareness in cancer screening, 




leading to detection of cancers at earlier stages.  These patients of early stage cancers 
have may have presented with lower incidence of cancer-related pain.  According to a 
systematic review, although cancer pain was reported in 59% of cancers of various 
stages, this prevalence increased to 64% in advanced stages[94].  However, use of 
oxycodone increased steadily from 2012 and increased use of such strong opioids is 
of concern, regardless of disease and pain severity. The degree of damage to society 
from misuse of opioids is reasonably potentiated when the opioid of concern is a 
stronger one.     
A sharp decline in use of morphine, and a gentler drop in use of oxycodone and 
tramadol after 2011 accompanied the rise in use of fentanyl (Figure 2). The increased 
use of convenient, long-acting fentanyl patches may have resulted in a reduced need 
to supplement our patients with immediate-acting opioids for breakthrough pain.  
However, even as fentanyl usage continued to rise, use of oxycodone and tramadol 
also rose, albeit much more slowly. A flip of tables occurred in 2013, which saw a 
sharp decline in use of fentanyl, with an accompanying rise in use of tramadol, 
morphine and oxycodone. While it may be valuable to investigate this change in 
opioid prescribing pattern, it is beyond the scope of this study. Codeine appeared to 
have been gradually replaced by stronger opioids. 
 
A strength in our study is that it allows us to observe the changing trends of opioid 
use in cancer-related pain in our cancer center.  Although use of weaker opioids like 
codeine and morphine declined from 2010 to 2014, the steady rise in use of stronger 
opioids like oxycodone was seen from 2012 to 2014.  This seems to mimic the trends 
seen in other developed countries like USA and Australia[89, 93].  It is logical to 
anticipate the same problems faced by these countries.  This finding may grant 




decision makers valuable time to address this potential problem while it is still in its 
infancy. 
 
However, there are several limitations to this study.  Consumption data does not 
directly account for amount of drug actually administered.  Patients may in reality be 
taking more (by obtaining opioids from other clinics) or less (prescription may not be 
completely filled) opioid medications than are currently reported.  There were no 
longitudinal data on opioid prescribing and outcomes in individual patients such as 
ED visits and mortality.  As such, we were unable to draw correlational relationships 
between amount of opioids prescribed and health-related outcomes such as 
hospitalizations and deaths.   Since information source is dispensing data, we were 
unable to measure prescribed dosages and days of opioid supplied.  As a result, it was 
neither possible to ascertain trends of adherence to opioids nor whether prescriptions 
were completely filled.  Lastly, the findings of this study do not include possible co-
prescribing if patients attended pain clinic outside of NCCS.  Hence, actual use of 
opioid analgesic by patients may be higher than reported. 
 
2.5 Conclusion 
In conclusion, despite increases in cancers diagnosed, our usage of opioids remained 
relatively stable.  However, a rise in use of stronger opioids such as oxycodone is 
observed. As there are serious associated problems with increased usage of stronger 
opioids overseas, we should watch our population closely as we continue to prescribe 
suitable analgesics for our patients.  
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Chapter 3. Evaluation of validity and reliability of the Pain and Opioid 
Analgesic Beliefs Scale – Cancer (POABS-CA) instrument 
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Despite remarkable advances in medical technology, cancer remains as one of the 
most feared diagnoses due to its accompanying short prognosis and debilitating 
symptoms.  Of these, the most significant till date is pain. According to the American 
Cancer Society[95], about 80% of patients with advanced cancer have un-managed 
moderate to severe cancer pain. It argued that the simplest and most inexpensive 
solution to this is by increasing the ease with which patients can obtain necessary 
analgesics. Doing so can potentially increase prognosis, in addition to being the 
solution of greatest impact to reduce discomfort from cancer pain. However, when 
patients themselves refuse pain medications, ready access to analgesics cannot remain 
a potent solution to this problem. 
 
Numerous barriers to pain management result in many patients not achieving optimal 
pain control. Patients’ reluctance to report pain and poor adherence to pain 
medications have been reported as major culprits[57] obstructing adequate pain 
management. These patient-related barriers include erroneous concerns or beliefs 
about pain medications such as fears of side effects and addiction, as well as the 
perception that good patients should not report about pain[57]. Previous studies have 
shown that some pain beliefs, which are representative of a person’s perception and 
evaluation of a pain episode, affect the way a patient reacts to pain[96, 97]. Therefore, 
misconceptions about opioid analgesics can potentially affect patients’ receptivity to 
such pain medications. 
 
Opioid analgesics are the cornerstone of cancer pain treatment. However, beliefs 
about use of opioids have been deeply polarizing. Negative beliefs about this class of 
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pain medications were frequently concerns about opioids’ side effects and their 
potential for addiction[57, 98]. Several instruments like the BQ (and BQ-II) and BMQ 
have been designed to measure patients’ beliefs about medicines. However Yeur-Hur 
Lai et al developed the Pain Opioid Analgesics Beliefs Scale in Cancer patients 
(POABS-CA)[59] to quantify this phenomenon specifically in opioid painkillers by 
cancer patients. This instrument allows us to address the opportune and intimately 
linked issues of cancer patients and their beliefs in opioids. The instrument attempts 
to evaluate two factors, negative effect beliefs and pain endurance beliefs, using 10 
items measured along a 5-point Likert-type scale. Developed and tested in Taiwan, 
the POABS-CA was found to possess satisfactory validity, reliability and stability, 
with Cronbach’s alpha of 0.70 and test-retest reliability of 0.94. According to the 
authors, all 10 items are intentionally worded using negative phraseology as this 
phrasing imitates how people usually express their beliefs about opioids[59]. 
 
The purpose of this study is two-fold: (1) to explore the feasibility of the POABS-CA 
in Singapore, and its (2) validity and reliability.  
In addition, chapter 3, which is a study on cancer patients’ adherence to opioid 
analgesics, piggybacks on the same subjects used for the validation study of POABS-
CA. Thus, it was a concurrent study of two objectives with the same subjects being 
administered an expanded list of questionnaires. As such, the discussion and 
conclusion for both studies will be combined at the end of chapter 3. 
 
3.2 Methods 
A two-phase psychometric analysis was performed to test the feasibility, validity and 
reliability of the POABS-CA using convenience sampling. Eligible subjects were (1) 
Chapter 3.  Evaluation of validity and reliability of the Pain and 




oncology patients of the National Cancer Center Singapore (NCCS) who (2) were 
above 21 years of age, (3) were prescribed opioid analgesics for cancer-related pain in 
the prior week at least, (4) able to speak coherently and (5) were not cognitively 
impaired as assessed by the recruiter. Institutional Review Board (IRB) approval was 
obtained for both phases of the study. Diagnoses were captured from electronic 
medical records. The researcher will be the person administering the questionnaires. 
 
Phase I: Feasibility of POABS-CA 
The specific aims of phase I were to ascertain the specificity and relevance of the 
domains that were established in POABS-CA in our patients. Pilot data were collected 
using a convenience sample of 30 cancer patients recruited at NCCS. POABS-CA 
was used to measure pain beliefs. Subjects were asked to complete the POABS-CA 
and then asked to comment on the ease of understanding the questions, the relevance 
of the questions and whether they are suitable for use in the Singapore culture. 
Specifically, the following questions were asked: (1) “Can you comment on the 
clarity of the questions? If you feel they are not sufficiently clear, can you suggest a 
way to improve it so it may be better understood?” (2) “Are you at any point 
uncomfortable in answering any of the questions? If so, which ones are making you 
feel uncomfortable and what do you suggest we can do about it?” (3) “Do you find 
any questions irrelevant? How so?” (4) “Do you feel that additional relevant questions 
should be added to the list? What are they?” 
 
Phase II: Validity and reliability of POABS-CA 
The specific aims of this phase were to test the (1) internal consistency reliability and 
test-retest reliability of the POABS-CA and (2) examine its construct validity with 
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confirmatory factor analysis using the “confa” command in STATA and known-group 
validity. A comparative fit index (CFI) of value 0.95 or greater is criteria for a good 
fit of the data to the model. 300 patients from NCCS were recruited. The sampling 
frame and inclusion criterion were the same as described previously for patients in 
Phase I. The Brief Pain Inventory Short Form (BPI-SF) measured pain experience and 
was interview-administered for the purpose of examining concurrent validity of the 
POABS-CA. The BPI-SF comprised of four items to assess pain intensity (worst, 
least, average, and current pain), seven items to assess pain interference, and one item 
to assess pain relief in the past 24 hours. The validity and reliability of BPI-SF for 
pain experience is well established[99, 100], with the instrument being used in many 
studies in various parts of the world. Thus, we have reasonable confidence that it can 
be applicable to our Singapore setting. In addition, it was developed for use in cancer 
patients, which fit into our study population. Cancer patients’ opioid beliefs is a 
subjective latent variable and while there is no standard “gold standard” measure of 
this phenomenon, we aimed to demonstrate the performance characteristics of the 
POABS-CA in relation to the BPI-SF since the BPI-SF’s validity and reliability is 
well established and it is commonly used in various studies to ascertain the impact of 
pain. Thus, BPI-SF was chosen as the “gold standard” in testing the validity of the 
POABS-CA. The hypothesis that patients having greater pain intensity on the BPI-SF 
will also report more negative beliefs on the POABS-CA will be tested and as such, 
convergent validity will be examined between BPI-SF and the POABS-CA. In 
addition, patients will be contacted by the researcher via telephone 2 days to one week 
after completion of the questionnaires and be asked the 10 questions in the POABS-
CA. This is for the intention of assessing the test-retest reliability of the instrument 
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(POABS-CA). The patients themselves will be required to answer the questions 
independently. 
The distributions of the level of agreements for each item in the POABS-CA were 
tabulated. As with the original Taiwanese POABS-CA development study, mean 
scores instead of summated scores were used because each of the POABS-CA items 




Cronbach’s alpha was calculated for internal consistency. Intra-class correlation 
coefficients were calculated for test re-test reliability. Pearson’s product moment 
correlations were calculated among POABS-CA total score, subscales and age, 
education, pain intensity on average, worst pain intensity and least pain intensity. The 
t-test was used to examine gender differences. POABS-CA total score, as well as 
negative effect and pain endurance beliefs subscales differences among the different 
races were analyzed with ANOVA.  
 
Confirmatory factor analysis was used to ascertain if the proposed beliefs subscales 
and factors were consistent. Pearson’s correlation coefficient was determined to 
investigate the relationship of the two beliefs (negative effect belief and pain 
endurance belief) and criterion-related variables such as age and pain intensity. 
Previous studies have shown that patients who were older as well as those who had 
less education[57, 101] had more negative beliefs about pain medication. It was also 
suggested that these patients were more likely to embrace values of enduring 
pain[102]. Gender differences were subjected to the t-test. 
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A convenience sample of 300 subjects recruited from NCCS included 129 men (43%) 
and 171 women (57%). Age ranged from 27 years to 89 years with a mean of 61 
years. 34 received no formal education (11.33%) while the rest had education ranging 
from primary school (n=90, 30%) to university and above (n=26, 8.67%). 
Participants’ diagnoses were most commonly breast cancer (29.67%), followed by 
lung cancer (13%) and colorectal cancer (10.33%), and all others being detailed in 
Table 3.1. POABS-CA total score (F(3,3) = 1.73, p = 0.16), as well as negative effect 
beliefs (F(3,3) = 2.07, p = 0.10) and pain endurance beliefs subscales (F(3,3) = 1.77, 
p = 0.15) did not differ among the difference races.  
 
Table 3.1 - Demographic and Disease Characteristics (n = 300) 
Characteristics Mean (SD) n Percent 
Age (years) 61.0 (11.1)   
    
Ethnicity    
   Chinese  246 82 
   Malay  34 11.33 
   Indian  18 6 
   Others  2 0.67 
    
Education    
    No education  34 11.33 
    Primary School  90 30 
    Secondary School  108 36 
    Pre-university/Junior college/A-level  22 7.33 
    Polytechnic/Diploma  20 6.67 
    University and above  26 8.67 
    
Gender    
    Male  129 43 
    Female  171 57 
    
Diagnosis    
    Breast cancer  89 29.67 
    Lung cancer  39 13 
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    Colorectal cancer  31 10.33 
    Nasopharyngeal cancer  30 10 
    Head and neck cancer  26 8.67 
    Prostate cancer  14 4.67 
    Liver cancer  13 4.33 
    Lymphoma  13 4.33 
    Cervical cancer  8 2.67 
    Gastric cancer  7 2.33 
    Ovarian cancer  7 2.33 
    Pacreatic cancer  6 2 
    Anal cancer  5 1.67 
    Esophageal cancer  3 1 
    Kidney cancer  2 0.67 
    Uterine cancer  2 0.67 
    Appendix cancer  1 0.33 
    Bone cancer  1 0.33 
    Endometrial cancer  1 0.33 
    Gallblader cancer  1 0.33 
    Sacral chordoma  1 0.33 
 
 
Feasibility of the POABS-CA 
The participants took 1 to 5 minutes to complete the POABS-CA. All participants 
commented that they felt the questionnaire to be easy to understand, wording of the 
questions were clear and they were easy to answer. 
 
Reliability of the POABS-CA 
The POABS-CA is shown in Table 3.2. Cronbach’s alpha for the POABS-CA was 
calculated to be 0.88. Item-to-total correlations for the 10 items were all above 0.5 
(Table 3.3). The least correlated was item 2 “Opioid medicine should only be used at 
the last stage of an illness” with item to total correlation of 0.5364, while the most 
highly correlated was item 7 “Adult patients should not use opioid medicine 
frequently” with alpha = 0.6767. Test-retest reliability of total score of POABS-CA 
for all 300 subjects was 0.99 (p-value < 0.0001). As this high correlation may be due 
to the wide variation in time to retest (4 to 8 days), with a large proportion (n =  231, 
Chapter 3.  Evaluation of validity and reliability of the Pain and 




77%) undergoing the retest after 4 or 5 days, a separate analysis for test-retest 
reliability was performed for only subjects who did the retest beyond 7 days (n = 67) 
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Table 3.2 - Pain Opioid Analgesics Belief Scale-Cancer (POABS-CA) 
In the following 10 statements, we ask for your beliefs about the use of opioids in 
cancer pain. Opioids or opioid medicines are 
also called narcotics by some people. Please circle the number that best shows 
your belief about opioid medicine and its use. 
0 = I strongly disagree. 
1 = I disagree. 
2 = I neither agree nor disagree. 
3 = I agree. 
4 = I strongly agree. 
1. Opioid medicine is not good for a person’s body. 0 1 2 3 4 
2. Opioid medicine should only be used at the last 
stage of an illness. 
0 1 2 3 4 
3. If a person starts to use opioid medicine, it 
means health is already in serious condition. 
0 1 2 3 4 
4. Opioid medicines cause many side effects.  0 1 2 3 4 
5. Side effects caused by opioid medicine are not 
easy to handle. 
0 1 2 3 4 
6. Adults should not ask frequently for pain 
medicine. 
0 1 2 3 4 
7. Adult patients should not use opioid medicine 
frequently. 
0 1 2 3 4 
8. The more opioid medicine a person uses, the 
greater the possibility that he or she might rely 
on the medicine forever. 
0 1 2 3 4 
9. If a person starts to use opioid medicine at too 
early a stage, the medicine will have less of an 
effect later. 
0 1 2 3 4 
10. An adult should endure as much pain as 
possible. 
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Table 3.3 - Mean Item Scores and Item to Total Correlations for POABS-CA 
(n=300) 
Items Mean SD Item to Total 
Correlation 
1. Opioid medicine is not good for a person’s 
body. 
2.02 1.023 0.5989 
2. Opioid medicine should only be used at the 
last stage of an illness. 
1.74 1.035 0.5364 
3. If a person starts to use opioid medicine, it 
means health is already in serious condition. 
1.78 1.12 0.6161 
4. Opioid medicines cause many side effects.  1.86 1.05 0.6226 
5. Side effects caused by opioid medicine are 
not easy to handle. 
1.82 1.03 0.6121 
6. Adults should not ask frequently for pain 
medicine. 
1.75 1.17 0.6527 
7. Adult patients should not use opioid 
medicine frequently. 
1.80 1.18 0.6767 
8. The more opioid medicine a person uses, the 
greater the possibility that he or she might rely 
on the medicine forever. 
2.07 1.15 0.5898 
9. If a person starts to use opioid medicine at 
too early a stage, the medicine will have less of 
an effect later. 
2.06 1.03 0.5579 
10. An adult should endure as much pain as 
possible. 
1.58 1.22 0.5419 
 
Construct validity of the POABS-CA 
Factor structures of the POABS-CA were examined using confirmatory factor 
analysis with the STATA command “confa”. 
The two factors, negative effect beliefs and pain endurance beliefs, have a moderate 
correlation (r = 0.51). Factor 1 contained 7 items from the negative effect beliefs 
subscale while factor 2 contained 3 items from the pain endurance beliefs subscale. 
Items 1, 2, 3, 4, 5, 8 and 9 loaded correctly to Factor 1 (negative effect beliefs) while 
items 6, 7 and 10 loaded distinctly as well to Factor 2 (pain endurance beliefs). 
CFI was found to be 0.8070. 
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Table 3.4 shows the Pearson’s product moment correlation among POABS-CA total 
score, subscales and age, education, pain intensity on average, worst pain intensity 
and least pain intensity.  
Pain endurance beliefs had no significant correlation with any of the proposed 
criterion variables. However, higher negative effect beliefs were significantly 
correlated with lower pain intensity on average (r = -0.22, P < 0.005) and lower worst 
pain intensity (r = -0.24, P < 0.0001). Higher POABS-CA total score was associated 
with lower average pain intensity (r = -0.20, P < 0.001) and lower worst pain intensity 
(r = -0.22, P < 0.001). Previous studies have shown that patients who were older and 
those who received less education had more negative beliefs about pain 
medications[57, 101], which was not shown in our study. Gender differences were 
also different from the original study, with females having more negative effect 
beliefs (Mean = 2.10, SD = 0.77) than males (Mean = 1.65, SD = 0.70) (t = -5.13, df = 
298, P < 0.0001). Likewise, females in our setting were found to have greater pain 
endurance beliefs (Mean = 1.82, SD = 1.14) than do males (Mean = 1.56, SD = 1.02) 
(t = -2.05, df = 298, P < 0.05).  
Table 3.4 - Correlations: Pain Beliefs versus Pain Sensory and Demographic 
Factors 
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The distributions of the level of agreements for each item in the POABS-CA are 
shown in Table 3.5. Mean scores of each item are shown in Table 3.3. Range of 
means was 1.58 (SD = 1.22) to 2.07 (SD = 1.15).  
 
3.4 Discussion 
Psychometric analysis of the POABS-CA in our local setting supported its overall 
satisfactory internal consistency reliability. Cronbach’s alpha for POABS-CA was 
0.91 and item-to-total correlation of each of the 10 items was above 0.5. Test-retest 
reliability (r = 0.99) over a period of 2 to 7 days was satisfactory. All the items from 
the two subscales, negative effect beliefs and pain endurance beliefs, loaded on their 
original subscales. Negative effect beliefs among our patients were significantly 
correlated with lower pain intensity on average (r = -0.22, P < 0.05) and lower worst 
pain intensity (r = -0.24, P < 0.05). This is surprising as these findings suggest that the 
more negative beliefs our patients had of opioid effects, the lower their reported 
average pain intensity as well as worst pain intensity. While this may at first seem 
contradictory, our patients who possess negative beliefs regarding opioids could be 
reticent at reporting pain for fear of being sternly reminded again to consume opioid 
analgesics. There were, in fact, multiple occasions where patients asked interviewers 
during the study if their choices in the study would change their pain treatment plan.  
 
Females in our study were found to score higher on both negative effect beliefs and 
pain endurance beliefs compared with males. This is again different from the original 
Taiwanese study, which showed males possessing greater pain endurance beliefs. 
This could be a reflection of true difference between both cultures with regard to 
attitudes about opioids, thereby strengthening the need to validate instruments despite 
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both cultures being superficially similar. Thus, the results of our study are consistent 
with the Taiwanese report in all but one variable: gender differences with negative 
effect beliefs. As with the original Taiwanese study[59], neither age nor education 
were significantly correlated to negative effect beliefs. They were also not 
significantly correlated with pain endurance beliefs. Authors of the original paper 
suggested that their findings of negative effect beliefs not being significantly 
correlated with variables of age, education and gender could be a universal 
phenomenon[59], which our study proved to be otherwise, at least in terms of gender 
differences. This may allow us to further streamline the phenomenon as such: that 
beliefs about negative effects of opioids not having significant correlation with age 
and education might be universal. Further research is needed to further refine these 
relationships.  
 
The multiracial setting in our population availed us the opportunity to analyze for 
differences in the beliefs scores as well as adherence status among the different 
ethnicities. It appears from our results that ethnicity is not a significant variable in 
Singapore. This could be a reflection of the homogeneity of values held among the 
races through lifetimes of acculturation. 
 
Each item’s mean score (Table 3.3) suggest that, unlike the original study, which had 
more than 50% of the patients rating 8 out of the 10 items a 3 (“I agree”) or 4 (“I 
strongly agree”)[59], our population was more evenly distributed with majority 
(between 20% and 45%) either rating a 1 (“I disagree”) or a 3 (“I agree”) for each of 
the items, with extreme choices being less popular. This may show that our 
population is fairly balanced in their beliefs about opioids and the value of enduring 
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pain. This observation may explain to a certain extent the relatively high level of 
adherence to opioid analgesics among our cancer patients. In addition, a significant 
proportion of patients rated a 3 (“I agree”) on questions about side effects (items 4 
and 5), which could be a reflection of inadequate management of opioid-induced 
adverse events in our setting.  
 
Internal consistency reliability of the POABS-CA is satisfactory, with negative effect 
beliefs subscale at 0.85, pain endurance beliefs at 0.90 and overall score at 0.88 as 
well. While all subjects completed the retest, the interval between administration of 
the first test and the retest was varied from 2 to 7 days. Test-retest reliability of total 
score of POABS-CA was 0.99 (p-value < 0.0001). Subjects in which at least 7 days 
have elapsed between first test to retest (n = 67), test-retest reliability was calculated 
to be 0.96 (p=value < 0.0001). However, our study results did not show good fit of the 
data to the model, as was observed from the CFI (0.8070), which was lower than our a 
priori criteria of 0.95. 
 
3.5 Conclusion 
In conclusion, the 10-item POABS-CA is a simple measure of patients’ negative 
opioid beliefs with a short completion time. Although it has shown to possess good 
internal consistency reliability and test-retest reliability, it does not exhibit concurrent 
validity with BPI-SF, which is of concern as it may mean that one could be measuring 
an unintended latent variable from what it was intended to measure. Thus, we need to 
be critical in the usage of POABS-CA in our local setting.  
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opioid analgesics  










Chapter 5. Conclusions 
  




5.1 Major findings 
In this thesis, we first performed a systematic review to summarize current literature 
with regards to the contexts in which cancer patients’ beliefs have been studied 
(Chapter 1). In addition to broadly outlining these contexts, we identified the 
measurement tools used in the studies for assessing cancer patients’ beliefs and 
critically appraised the content and psychometric properties of these instruments 
(Tables 1.2 and 1.3). We also found that the POABS-CA, a 10-item instrument 
developed to assess cancer patients’ negative beliefs on opioid analgesic use, was a 
relevant tool that was relatively newly developed which would benefit from validation 
in our local setting, which was the direction this thesis took in the subsequent 
chapters. This instrument was chosen, as it was cancer specific and opioid specific, 
which fit our thesis objective of understanding cancer patients’ beliefs in relation to 
their adherence to supportive care. 
 
We next looked at the prevailing trend of opioid usage at a large local ambulatory 
cancer center (Chapter 2) to allow appreciation of the scope of our study we wished to 
undertake. This availed us with knowledge that while our opioid usage did not reach 
the levels experienced in US or Australia, a slow but steady rise in use of stronger 
opioids was observed which can potentially lead to the problems faced by these 
countries related to use and abuse of opioids. This is especially of concern, as the 
number of cancer patients using opioids did not significantly increase over the years, 
suggesting that our individual patients have been using more opioids over the years. 
 
Following up to that, we explored the feasibility of the POABS-CA in Singapore as 
well as its construct validity and reliability (Chapter 3). From this validation study, we 
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found that the POABS-CA in our local setting exhibited satisfactory feasibility, 
internal consistency reliability and test-retest reliability. The participants took only a 
short time (1 to 5 minutes) to complete the POABS-CA and all commented that they 
felt the questionnaire to be easy to understand, that the wording of the questions were 
clear and that they were easy to answer during the interviewer-administered sessions. 
However, the POABS-CA did not show convergent validity with the BPI-SF, which 
brought up issues with interpretation of its results. This could either be due to actual 
differences between the original Taiwanese population and our local population, or it 
could be a manifestation of a more complex underlying cognitive reflex mechanism 
among our patients. In addition, due to the study being interviewer-administered, 
probable issues such as social desirability bias, which can obscure the intended 
outcomes the instrument was designed to measure, could not be ruled out. While the 
POABS-CA was originally devised as a self-report questionnaire, the low literacy of 
our elderly (majority) patients necessitated the use of interviewers conducting the 
study in various languages. Thus, the results of this study should be taken with this 
consideration in mind. 






In conclusion, this thesis has contributed to new knowledge to the understanding of 
cancer patients’ beliefs in a few ways. Firstly, to the best of our knowledge, we have 
performed the first systematic review of current literature on studies done to measure 
cancer patients’ beliefs. This allows us to appreciate the aspects of cancer patients’ 
beliefs that are suitable and valuable for further study. Second, we have established 
the background opioid analgesic usage in our local ambulatory cancer center. Third, 
we isolated and performed validation studies on a relevant tool used to measure 




The limitations of the studies have been detailed in the preceding chapters and shall 
be summarized here. Firstly, our systematic review only included English-language 
articles and excluded those published only as abstracts.  We also could not assess 
publication bias because of the lack of evidence. Second, as consumption data does 
not necessarily equate to amount of opioid actually taken, patients may in reality be 
taking more or less opioid medications than was reported. Third, as our validation and 
adherence studies were interviewer-led, social desirability bias could not be 
discounted. This potentially obscured, to an extent, the intended outcomes the 
instrument was designed to measure. Unfortunately, this could not be addressed in our 




studies as a large proportion of our cancer patients were illiterate, necessitating the 
need for an interviewer to both translate and verbalize the questions asked in the 
instruments.  Additionally, due to the self-report nature of both our measures of 
adherence, biases may not be entirely mitigated by our use of 2 separate tools for this 
purpose.  
  





 5.4 Recommendations for future studies 
While carrying out the studies, several thoughts for further research arose. The 
following are some of the new research questions proposed: 
 
1. Do adjuvant pain medications significantly affect beliefs regarding opioid use? 
 
Adjuvant pain medications lack the social stigma associated with opioids. As a result, 
their preferential use by cancer patients may help reduce cancer pain to such an extent 
as to affect response to questionnaires measuring opioid beliefs and their adherence. 
In order to make meaningful conclusions about opioid beliefs, we need to take into 
account patients who were using co-analgesics such as NSAIDs and anti-neuropathic 
agents. A separate study on patients not on these adjuvant treatments could potentially 
clarify our results. 
 
2. Do our patients possess the cognitive reflexes of favoring positive responses to 
POABS-CA items in order to avoid possible confrontation with interviewers who may 
sternly remind them to adhere to their opioid regimen? 
 
In order to determine that this cognitive aspect did not corrupt the results from our 
POABS-CA study, we may need to ascertain whether our patients possess such 
attitudes in the first place. This can then lead to more meaningful data gathering and 
subsequent interpretation of results. 
 




3. Why do females among our cancer patients seem to possess more negative 
opioid beliefs than males? 
 
Unraveling this phenomenon can bring us a step closer to understanding how cancer 
patients possess negative opioid beliefs and how culture and social constructs of 
gender roles contribute to this difference. 
 
4. What can be done for patients who possess negative opioid beliefs? 
 
While our studies did not show a significant link between negative opioid beliefs and 
adherence, it is nevertheless worth having appropriate interventions in place to reduce 
such beliefs in our cancer patients, especially in light of the argument that there could 
be potential confounders due to administration of adjuvant analgesics and subject 
social desirability bias. A possible future work could be isolating interventions only to 
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